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1.1 The heat shock protein family: the very short overview 
 In both prokaryotes and eukaryotes, transcription of most genes for heat shock proteins 
(HSPs)  is induced by environmental stress conditions and various agents, including heat shock, 
anoxia, heavy metals, and certain inhibitors of mitochondrial respiration (Lindquist and Craig, 
1988 ; Welch, 1992). HSPs in mammalian cells are classified into several families based on their 
apparent molecular mass and degrees of structural homology. HSPs are subdivided into small 
HSPs (25-28 kDa), HSP40 (40kDa), HSP60, HSP70 (68-80 kDa), HSP90 (83-99 kDa), and high-
molecular-weight HSPs (110 kDa). Many members of these subfamilies are in fact not heat 
inducible, but their expression is induced in a tissue-specific manner or during development. The 
number of genes encoding the different HSP members varies between organisms. The number of 
genes encoding the diverse HSP family members largely varies per organism. For HSP70, the 
number of genes varies from three in Escherichia coli, 14 in Arabidopsis thaliana, 12 in 
Drosophila melanogaster and 13 in Homo sapiens. For small HSP (sHSP), the number of genes 
is relatively high in plants and the same holds true for HSP40 (Table 1.1) (Vos et al., 2008).  
HSPs act as molecular chaperones that recognize unfolded or newly translated proteins and 
promote acquisition of the functional native state (Frydman, 2001). Therefore, molecular 
chaperones prevent the aggregation of unfolded and damaged proteins in cells. Severely damaged 
proteins are selected by a process termed protein quality control, in which the chaperone HSP70 
in collaboration with other proteins such as E3 ubiquitin ligase target the damaged proteins for 
degradation via the ubiquitin-proteasome pathway (Connell et al., 2001; McDonough and 
Patterson, 2003).  
 
 
1.2 The heat shock protein family 110 (HSP110) 
The Hsp110 gene family includes two genes in Saccharomyces cereviae known as SSE1 
and SSE2 and four genes in the mammalian genome, namely, Hspa4l/Apg1, Hspa4/Apg2, 
Hsph1/Hsp105 and Hyou1/Grp175/orp150. Except HYOU1 that is present in endoplasmic 
reticulum, all other members of mammalian and yeast HSP110 are found in the cytosolic 
compartment. Constitutive expression of Hspa4l is high in testis and moderate in other tissues, 
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while Hspa4 and Hsph1 are expressed in various tissues (Morozov et al., 1995; Kojima et al., 
1996; Kaneko et al., 1997, Kojima et al., 2004).  
 
Table 1.1. Number of Hsp genes in different species (Vos et al., 2008). 
 
                                                           HSPA/H           HSP40                sHSP                genome size (bp) 
H. sapiens 13  41 11 3.3 × 109 
D. melanogaster 12 36 11 1.2 × 108 
A. thaliana 14 89 19 1.1 × 108 
Saccharomyces cerevisiae 14 22 2 1.2 × 107 




Primary structure of HSP110 proteins is highly related  to HSP70 and consists of a nucleotide-
binding domain (NBD) and a peptide-binding domain (PBD) that are connected by a flexible 
linker region (Mayer and Bukau, 2005; Liu and Hendrickson, 2007). However, biochemical 
analyses revealed that HSP110 members serve as cochaperones of mammalian and yeast HSP70 
chaperones and act as molecular exchange factors (NEF) during the ATP-hydrolysis cycle (Steel 
et al., 2004; Dragovic, 2006; Shaner and Morano, 2007). Binding of newly synthesized 
polypeptides to HSP70 chaperones and the subsequent release of folded proteins is regulated by a 
continuous cycle of ATP-hydrolysis and exchange of ATP to ADP (Fig. 1.1). In the ATP-bound 
state, PBD of HSP70 chaperone binds to polypeptides with low affinity. However, ATP-
hydrolysis to ADP by HSP40 cochaperone leads to conformational changes that result in high 
affinity substrate binding by HSP70. To complete the protein folding cycle, binding of HSP110 
NEF to HSP70 in the ADP-state stimulates the release of ADP. Subsequent binding of ATP 
induces the disassociation of HSP70-HSP110 complexes (Polier et al, 2008).  
The cellular functions of the HSP110/SEE gene family members were determined in several 
species. In S. cerevisiae, deletion of SSE1 results in a reduction of cell proliferation and 
temperature sensitivity, whereas the depletion of SSE2 has no effect on proliferation. However 
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deletion of both SSE1 and SSE2 genes is reported to be lethal in some strain backgrounds, 
indicating a unique important cellular function of these proteins in yeast (Mukai, et al., 1993; 



















Fig.1.1 Model for the cooperation of HSP110 and HSP70 in protein folding. Recruitment of 
HSP70 (red) to unfolded substrate protein (green) is assisted by J-domain proteins (HSP40, 
orange; step 1). Complex formation between HSP70 and HSP110 (blue) displaces ADP from the 
HSP70 partner (step 2). Direct substrate binding to HSP110 may provide an anchor aiding the 
unfolding of kinetically trapped intermediates through thermal motions of the PBD of HSP70. 
Finally, upon binding of ATP to HSP70, the HSP70-HSP110 complex dissociates and the 
substrate protein is released for folding (step 3). The green circle indicates natively folded 





The physiological function of the mammalian HSP110 gene family has been studied by 
analysis of knockout mice. Analysis of Hspa4-/- deficient mice revealed that Hspa4l is not 
essential for embryonic development and Hspa4l-deficient mice were indistinguishable from their 
wild-type littermates in appearance and gross behavior. However, approximately 42% of mutant 
males are infertile. The cause of the male infertility is due to reduction of sperm count and sperm 
motility. Further analysis revealed that the reduction of sperm number is due to the elimination of 
a significant number of developing germ cells via apoptosis. No defect in fertility was observed 
in Hspa4l-deficient females (Held et al., 2006). In addition, Held et al. (2006) found that Hspa4l-
/- mice were preferentially susceptible to osmotic stress. Nakamura et al. (2008) have studied the 
physiological function of Hsph1/Hsp110, which is ubiquitously expressed. They found that the 
deletion of Hsph1 did not affect the embryonic development, viability and fertility of mutant 
mice.  However, Hsph1/Hsp110 knockout mice are resistant to ischemic injury and that the 
protective effects of Hsph1 deficiency in cerebral ischemia may be mediated by an increase in the 
chaperone activity of HSP70. 
 
1.3 Expression and function of Hspa4 
 In mouse, Hspa4 gene was mapped to chromosome 11, region B1.3 and consists of 19 exons. 
The Hspa4 cDNA has a length of 2832 bp, encoding for a polypeptide of 841 amino acids with a 
molecular weight of 94,1 kDa. The HSPA4 protein shows about 65% sequence identity with 
HSPA4L protein (Kaneko et al., 1997). Although HSPA4 protein is highly homologous in amino 
acid sequence to human HSP70RY (94%), HSPA4 is longer than HSP70RY by 140 amino acid 
sequence at its C-terminus. Expression analysis revealed that the transcript level of Hspa4 is not 
induced by heat shock (Kaneko et al., 1997; Nonoguchi et al., 1999; Okui et al., 2000). In the 
adult mouse, Hspa4 mRNA is detected in most tissues, with the highest expression in testis, 
ovary and spleen (Nonoguchi et al., 1999). Hspa4 transcripts were detected in cells of various 
origins, including embryonic fibroblasts, embryonal carcinomas, myelomonocytic leukemia, 
mastocytoma, Sertoli cells and bone narrow stromal cells (Kaneko et al., 1997). 
 
In addition, the Hspa4 gene has been found as one of 250 genes, which are highly expressed in 
the pluripotent stem cells (Ramalho-Santos et al., 2002). Two Hspa4 transcripts of 3.2 and 4.8-kb 
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were found by in Northern blot analysis. However, protein analysis revealed that an anti-HSPA4 
antibody only detect a 94-kDa protein in all studied tissues. These results suggest that both Hspa4 
RNA isoforms result from alternative splicing of the 3'- untranslated region (Held, 2008). 
Analysis of HSPA4 expression during germ cell development revealed that the expression is 
highly enriched in male and female germ cells of prenatal gonad. Expression of HSPA4 in male 
gonocytes is gradually decreased after migration to basement layers of seminiferous tubules and 
differentiation to spermatogonia (Held, 2008). In brain, HSPA4 protein was found to be 
expressed constitutively in rat neuronal tissues throughout development (Ogita et al., 2001) and 
primary human articular chondrocytes (Dehne et al., 2010).  
 HSPA4 was identified as a new interaction partner of the protein zonula occludens (ZO-
1), which is associated with tight junction proteins at cell membrane. This interaction between 
HSPA4 and ZO-1 regulates the function of ZO-1 in control of the cellular localization of the 
transcription factor ZO-1 associated nucleic acid binding protein (ZONAB/DbpA/Csda). Binding 
of ATPase domain of HSPA4 to the SH3 domain of ZO-1 competes with the binding of  ZONAB 
to SH3 domain of ZO-1, resulting in the release the ZONAB from the complex with ZO-1, 
transport to the nucleus and stimulates the transcription of genes encoding cell cycle regulators 
such as cyclin D1 and PCNA. Cyclin D1 and PCNA regulate the G1/S phase transition (Balda et 
al., 2003; Tsapara et al., 2006). Both HSPA4 and ZONAB are required for normal proliferation 
and regulate entry to S-phase. Thus, only little HSPA4 is associated with ZO-1 under control 
conditions. On heat shock, however, HSPA4 is redistributed, not upregulated, resulting in 
accumulation in nucleoli and at intracellular junction. It is conceivable that HSPA4 stabilizes 
tight junctions during stress conditions (Tsapara et al., 2006). In hepatocellular carcinoma and 
pancreatic cancer cells, HSPA4 as well as human ZONAB homologue DbpA are overexpressed 
(Nakatsura et al., 2001; Hayashi et al., 2002; Gotoh et al., 2004) suggesting that ZONAB 
signaling becomes activated,  because most of its interacting protein ZO-1 becomes associated 
with the HSPA4 (Tsapara et al., 2006).  
Recently, it has been showed that overexpression of Hspa4 in chronic myelogenous 
leukemia cells (BaF3-BCR/ABL cells) increases cell proliferation and protects cells from 
oxidative damage, which may play an important role in chronic myelogenous leukemia 




To analyze the function of HSPA4 in mammalian species, Hspa4 was disrupted by 
homologous recombination in the mice (Held, 2008). Two lines of Hspa4-deficient mice were 
generated in hybrid C57BL/6J x 129/SV and inbred 129/Sv genetic background. Analysis of 
Hspa4-deficient mice in hybrid C57BL/6J x 129/SV genetic background revealed that 
approximately 62% of Hspa4-deficient males in F2 generation are infertile due to a significant 
reduction in sperm number and motility. No defects in fertility were observed in female mutants. 
Analysis of Hspa4-deficient mice in the inbred background showed that 94,1% of Hspa4-
deficient mice display growth retardation and died between the third and fourth week after birth. 
Male and female deficient animals, which overcome the early lethality display impaired fertility. 
Kyphosis was developed in Hspa4–deficient mice of advanced age. Anatomical analysis of   adult 
Hspa4-/- heart showed enlargement of heart size. In addition, deficiency of Hspa4 gene causes 
skeletal muscle myopathy in adult Hspa4-/- mice (Held, 2008).  
 
1.4 Aims of the study 
In context of this work, several questions must be addressed. What are the underlying 
causes of male infertility, growth retardation and skeletal muscle myopathy in Hspa4-deficient 
mice? What are the signaling pathways that are disturbed in the cardiac hypertrophy in mutant 
mice? Therefore, the aim of my study was to determine the underlying causes of male infertility, 
growth retardation and cardiac hypertrophy in Hspa4-/- mice. To reach these goals, studies were 
performed and categorized as follows: 
1. To determine the cause of disruption of spermatogenesis in Hspa4-/- mice, the progress of 
male germ cell development in mutant mice was studied at different stages of postnatal 
development. 
2. To determine whether growth retardation is due to skeletal muscle myopathy, histological 
analysis of different types of skeletal muscle were performed at different postnatal 
development. 
3. Development of cardiac fibrosis and hypertrophy in the Hspa4-/- heart was determined during 
postnatal life using different histological and molecular analyses. 
4. To determine the molecular pathways, which are mediating the cardiac fibrosis and 
hypertrophy, a microarray assay was performed and the expression of differentially expressed 
genes in Hspa4-/- heart was confirmed by quantitative RNA and protein analysis. 
Materials and Methods 
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Invitrogen, Karlsruhe 
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Difco, Detroit, USA 
Difco, Detroit, USA 
Boehringer, Mannheim 
Biomol, Hamburg 







ICN Biomedicals, Eschwege 
Baker, Deventer, NL 
Sigma, Deisenhofen 
Fluka, Neu Ulm 
 
Invitrogen, Karlsruhe 
Amersham Pharmalia, Freiburg 
Invitrogen, Karlsruhe 
Fluka, Neu Ulm 
Sigma, Deisenhofen 
Acetic acid 










BSA   
Chloroform  
Cardiotoxin                                                   
Coomassie Blue G-250  
Diethyl pyrocarbonate (DEPC)  






Eukitt-quick hardening mounting 
medium 
FBS   
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Invitrogen, Karlsruhe 




MIsopropanol      erck, Darmstadt 
Invitrogen, Karlsruhe 
Invitrogen, Karlsruhe 
MKCl       erck, Darmstadt 
Merck, Darmstadt 
MMethanol      erck, Darmstadt 
S2-Mercaptoethanol     erva, Heidelberg 




MNaH erck, Darmstadt 





SOrange G      igma, Deisenhofen 
MParaformaldehyde     erck, Darmstadt 
Sigma, Deisenhofen 





Fulka, Neu Ulm 
Biorad, Sigma 
A[ mersham Pharmalia, Braunschweig 
Amersham Pharmacia, Freiburg 
Glycerol     
Goat serum  
HCl  
H2O2 
1 kb DNA Ladder     
100 bp DNA Ladder   
KH2PO4  
Milk powder     
NaCl      
Na2HPO4     
2PO4      
3      
NaOH 
NuPAGE Novex Bis-Tris 4-12% Gel 
NuPAGE MOPS SDS running buffer 
NuPAGE SDS sample buffer   
Paraquat                                                        
Penicillin/Streptomycin    
Peptone   
Phenol   
Phosphoric acid     
Picric acid     
Protein marker    
32P]-dCTP      
RediprimeTM II    
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SSodium acetate     igma, Deisenhofen 
Sodium citrate 







VVectashield (DAPI)     ector, Burlingame 
BX-Gal       iomol, Hamburg 
MXylene      erck, Darmstadt 
RYeast extract      oth, Karlsruhe 
RNase A     
RNase away     
RNase Inhibitor    
RNA length standard    
Saccharose                                                    
Salmon sperm DNA     
SDS      
SeeBlue Plus2 Pre-Stained 
StandardSelect Peptone  
Gibco/BRL, Eggenstein 
S.O.C Medium    
Sun flower oil    
T4 DNA ligase     
Trifast  reagent     
Tris base     




2.1.2 Solutions, buffers and media 
 
All standard buffers and solutions were prepared according to Sambrook et al. (1989). 
 
 
Bouin’s solution             15 volume of Picric acid (in H2O) 
                                                                                           5 volumes of 37% Formaldehyde 
                                                                                           1 volume of Acetic acid 
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Ligation buffer (10x)              600 mM Tris/HCl (pH 7.5) 
                                                                                            80 mM MgCl2 
                                                                                            100 mM DTT 
 
Loading buffer                15% Ficoll 400 
                                                                                             10 mM EDTA (pH 8) 
                                                                                             0.25% Orange G 
                                                                                             1% Glycerol 
 
Lysis buffer I                 100 mM Tris/HCl (pH 8.0) 
                                                                                              100 mM NaCl 
                                                                                              100 mM EDTA 
0.5% SDS 
 
SSC (20x)                  3 M NaCl 
 0.3 M sodium citrate (pH 7.0) 
 
TBE buffer (5x)                 450 mM Tris base 
  450 mM Boric acid 
  20 mM EDTA (pH 8) 
 
TE buffer                   10 mM Tris/HCl (pH 8.0) 
                                                                                                1 mM EDTA 
 
2.1.3 Laboratory materials 
The laboratory materials, which are not listed here, were bought from Schütt and 
Krannich (Göttingen). 
 
Culture slides        BD Falcon, Heidelberg 
Disposable filter Minisart NMI     Sartorius, Göttingen 
Filter paper 0858       Schleicher and Schüll, Dassel 
Hybond C        Amersham, Braunschweig 
Hybond N        Amersham, Braunschweig 
HPTLC Aluminum folio      Merck, Darmstadt 
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Microcentrifuge tubes      Eppendorf, Hamburg 
Petri dishes        Greiner, Nürtingen 
Pipette tips        Eppendorf, Hamburg 
RotiPlast paraffin       Roth, Karlsruhe 
Transfection flasks       Lab-Tek/Nalge, Nunc, IL, USA 
Superfrost slides       Menzel, Gläser 
Whatman blotting paper      Schleicher and Schüll, Dassel 
(GB 002, GB 003 and GB 004) 
X-ray films        Amersham, Braunschweig 
 
2.1.4 Sterilisation of solutions and equipments 
All solutions that are not heat sensitive were sterilised at 121°C, 105 Pa for 60 min in 
an autoclave (Webeco, Bad Schwartau). Heat sensitive solutions were filtered through a 
disposable sterile filter (0.2 to 0.45 μm pore size). Plastic wares were autoclaved as above. 
Glasswares were sterilised overnight in an oven at 220°C. 
2.1.5 Media, antibiotics and agar-plates 
 
2.1.5.1 Media for bacteria 
 
LB Medium (pH 7.5)       1% Bacto-trypton 
 0.5% Yeast extracts 
1% NaCl 
 
LB-Agar        1% Bacto-trypton 
0.5% Yeast extracts 
1% NaCl 
1.5% Agar 
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2.1.5.2 Antibiotics 
Stock solutions were prepared for the antibiotics. They were filtered through sterile 
disposable filters and stored at –20°C. When antibiotics were needed, in each case, they were 
added after the autoclaved medium has cooled down to a temperature lower than 55°C. 
Antibiotics   Stock solution     Working solution 
Ampicillin   50 mg/ml      50 μg/ml 
Kanamycin   25 mg/ml      50 μg/ml 
 
2.1.5.3 IPTG/X-Gal plate 
 
LB-agar with 50 μg/ml ampicillin, 100 μM IPTG and 0.4% X-Gal was poured into  
Petri dishes. The dishes were stored at 4°C. 
 
2.1.6 Bacterial strains 
 
E. coli DH5α      K-12 strain,F- Φ80d lacZΔM15 endA1 
recA1 hsdR17 (rk-, mk+) sup E44 thi-1 





pGEMTeasy       (Promega, Wisconsin, USA) 
 
2.1.8 Synthetic oligonucleotides 
 
The synthetic oligonucleotide primers used in this study were obtained from OPERON 
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2.1.8 .1 Primers used for  generation of cDNA probes  
Name Sequence 
Acr_F                                      
Acr _R                                     
Hsc70t_F                                 
Hsc70t _R                               
Tnp2 _F                                   
Tnp2_R                                   
Anf_F                                      
Anf_R                                      
Bnf_F                                      
Bnf_R                                      




























5`- GTTGCAGCAGTGGGAACTGG -3' 
5`- CTAAAGGCATGCCTCTTAGC -3' 
5`- TCTCATGAGTCACCTCGGTCG -3' 
5`- AACTGTGAGCCCGATGTGCAG -3' 
5`- GTGGAGGAGATCGACAGGTATC -3' 
5`- CTCACACAGAGACACGTTCAC-3' 
5`- CCAACAGAAATGTCCACAGAGA -3' 
5`- AGCCACTGGAGGATGTGAGTAT -3' 
 
2.1.8.2 Genotyping primers 
Apg2-genotyping _F 
Apg2-genotyping _R  
Apg1- genotyping _F  
Apg1- genotyping_R  
PGK3  
5`- GATCACGGGAAGTGAGTGGT -3' 
5`- GAGCGGGAGTGAGACAGTTC -3' 
5`- GGTCAGAAAGGCTCACCAAGG -3' 
5`- ACTGAGGCCCTTGATTTGGCC -3' 
5`- TCTGAGCCCAGAAAGCGAAGG -3' 
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Hcn1 _F  












Maob_R                                  
Kcne1 _F                                 
Kcne1 _R                                
Gnao1 _F                                 











5'- AGCTCCCTGATTGCCTGTGT- 3' 
5'-TTTGGCCCTGGTCTCACTTT- 3' 
5`- AGCTTCCTGAGATGGACATTG -3' 
5`- CGAGGTCCCCTAAAAACTGA -3' 












  5`–AAACCAGATGGCACCTATGC- 3` 
5` –GCTTCTTGGGAGTTCAGCAC- 3' 
5' –AATTGTCCTCCGTTCTCCAC- 3 
5' –CTGTGGGGGTTGCTTTTAAT- 3' 
5' –AGTCAAAACAACTGGCATCG- 3' 
5'– TCAAACAGCCTGAAGTGGAG- 3' 

















ET-BR_R                                
Collagen 1_F   
Collagen 1_R       
Calmodulin 1_F    
Calmodulin 1_R   
TGF-ß1 _F    
TGF-ß1 _R    
Mef2C_F      
Mef2C_R       
Hdac 7a_F   






5`-CCAGGAAACATCAGTGAGTCC - 3` 
5`-GGATGGAACTTGGAATCGGTCA - 3` 
5`-GGTGGCTCTTTGGGTTCT - 3` 
5`-GACGCTGTTTGAGGTGCT - 3` 
5`-TGCGAAATGCTCAGGAAG - 3` 
5`-ACGAGGACCAGGCAGAAG - 3`  
5`- AGGCTTCAGTGGTTTGGATG- 3` 
5`- CACCAACAGCACCATCGTTA- 3` 
5`- AGGGGTTTGGAGGTGACTTT - 3` 
5`- TTCCTCGGAGGTTAGGGTTT - 3` 
5`- TGAGTGGCTGTCTTTTGACG- 3` 
5`- GGTTCATGTCATGGATGGTG- 3` 
5`-ATTTGGGAACTGAGCTGTGC- 3` 
5`- CGCTCATCCATTATCCTCGT- 3` 
5`- ATCTCTTCCTGGCAGGCTTA- 3` 
5`- TTCTGCTTGACCACACTGCT- 3` 
 
2.1.9 Mouse strains 
Strains C57BL/6J, 129/Sv, CD-1 and NMRI were initially ordered from Charles River 
Laboratories, Wilmington, USA, and kept at Animal Facility of Institute of Human Genetics, 




Rabbit anti -HSP110 polyclonal antibody          
Rabbit anti -Apg1 polyclonal antibody  
Rabbit anti -Apg2 polyclonal antibody 
Mouse monoclonal anti -α-tubulin  
mouse anti -GCNA1 monoclonal antibody              
Sigma, Steinheim 
Santa Cruz Biotechnology, Heidelberg 
Santa Cruz Biotechnology, Heidelberg 
Sigma, Deisenhofen 
G. Enders, University of Kansas, USA 
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Rabbit anti -SCP3(Syp3) polyclonal antibody 
Goat anti-mouse IgG alkaline phosphatase 
conjugate  
Goat anti-rabbit IgG alkaline phosphatase 
conjugate  
Rabbit anti-mouse IgG Cy3 conjugate  
Rabbit anti-mouse IgG FITC conjugate   
Goat anti-rabbit IgG horse radish preoxidase 
conjugate    
Rabbit anti-mouse IgG horse radish preoxidase 
conjugate  
Rabbit anti-STAT3  polyclonal antibody 
 
Rabbit anti-phospho-STAT3 polyclonal antibody 
Rabbit  Anti-MAP Kinase (ERK-1, ERK-2) 
polyclonal antibody 
Rabbit  Anti-phospho- ERK-1 and Anti-
phospho- ERK-2  polyclonal antibody 
 











New England Biolabs, Frankfurt  
 
New England Biolabs, Frankfurt  
New England Biolabs, Frankfurt  
 




Immolase DNA Polymerase      (Bioline, Luckenwalde) 
Proteinase K        (Sigma, Deisenhofen) 
Platinum Taq polymerase      (Invitrogen, Karlsruhe) 
Restriction enzymes (with supplied buffers)               (Invitrogen, Karlsruhe) 
RNase A        (Qiagen, Hilden) 
RNase inhibitor       (Invitrogen, Karlsruhe) 
Superscript-II        (Invitrogen, Karlsruhe)  
T4 DNA ligase       (Promega, Mannheim) 
Trypsin        (Invitrogen, Karlsruhe) 
DNase I Amplification Grade                                                (Invitrogen, Karlsruhe) 
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2.1.12 Kits 
 
Labelling System     
Megaprime DNA Labeling Kit   
Mini Plasmid Kit   
PCR Purification Kit     
QIAquick Gel Extraction Kit    
RediprimeTM II Random Prime                         
Masson's trichrome stain Kit                                    
Periodic Acid Schiff Kit (PAS)    
ApopTag® plus peroxidase                          
               
Qiagen, Hilden 




 Amersham Pharmacia, Freiburg 
Sigma, Deisenhofen 
Sigma, Deisenhofen 
Qbiogene, Heidelberg, Germany 
 
2.1.13 Equipment 
Autoclave     
Centrifuge 5415D    
Centrifuge 5417R   
Biophotometer    
DNA Sequencer Modell Megabace 1000 
Microscope BX60    
GeneAmp PCR System 9600  
Histocentre 2 embedding machine 
Microtiterplate-Photometer   
Molecular Imager FX  
Phosphoimager Screen   
Semi-Dry-Blot Fast Blot 
Spectrophotometer Ultraspec 3000 
SpeedVac concentrator SVC 100H 
Thermomixer 5436   
TurboblotterTM   
UV StratalinkerTM1800    






(Perkin Elmer, Berlin) 
(Shandon, Frankfurt aM.) 
(BioRad laboratories, München) 
(BioRad laboratories, München) 
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2.2 Methods 
2.2.1 Isolation of nucleic acids 
2.2.1.1 Small-scale isolation of plasmid DNA 
 (adapted from Birnboim and Doly, 1979).  
         A single E.coli colony was inoculated in 5 ml of LB medium with the appropriate 
antibiotic and incubated in a shaker for 16 hrs at 37°C with a vigorous shaking. 0.5 ml of this 
culture was used for making glycerol stock (0.5 ml of culture and 0.5 ml of glycerol) and rest 
of the culture was centrifuged at 5000 x g for 10 min. The pellet was resuspended in 100 μl of 
solution P1. The bacterial cells were lysed with 200 μl of P2 solution and then neutralized 
with 150 μl of P3 solution. The precipitated solution was centrifuged for 10 min at 10,000 xg 
at 4 °C. The supernatant was transferred into a new tube and centrifugation was done again. 
The supernatant was transferred again into a new tube and 1 ml of 100% ethanol was added to 
precipitate the DNA. It was then stored in ice for 15 min, centrifuged at full speed for 20 min, 
and finally the pellet was washed with 70% ethanol and after air-drying was dissolved in 50 μl 
of Ampuwa water. 
P1: 50 mM Tris/HCl, pH 8.0; 10 mM EDTA; 100 μg/ ml RNase A 
P2: 200 mM NaOH; 1% SDS 
P3: 3 M Potassium acetate, pH 5.5 
 
2.2.1.2 Isolation of genomic DNA from tissue samples 
         (Laird et al., 1991) 
Routinely 0.5 cm of the mouse tail was incubated in 700 μl of lysis buffer I containing 
35 μl proteinase K (10 μg/μl) at 55°C overnight in thermomixer . The tissue lysate was 
centrifuged at 10,000 xg for 15 min. Then, DNA was precipitated from supernatant  by adding 
an equal volume of isopropanol, mixed  and centrifuged at 10,000 xg at RT for 15 min. DNA 
was washed with 1 ml of 70% ethanol, dissolved in 50-100 μl of dH2O and incubated at 60°C 
for 10 min. 
 
2.2.1.3 Isolation of total RNA from tissue samples  
(Chomczynski and Sacchi, 1987). 
The composition of Trifast Reagent, which was used for RNA extraction contained   
phenol and guanidine thiocyanate in a monophase solution. In order to avoid any RNase 
activity, homogenizers which were used for RNA isolation were treated before with RNase 
away and DEPC water. 100 mg tissue sample was homogenised in 1 ml of RNA reagent by 
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using a glass-teflon homogenizer. The sample volume should not exceed 10% of the volume 
of reagent used for the homogenisation. The homogenate was vortexed and incubated on ice 
for 5 min to permit the complete dissociation of nucleoprotein complexes. Then, 0.2 ml of 
chloroform was added, mixed and stored at 4°C for 10 min. After centrifugation at 12000 xg 
for 15 min at 4°C, the upper aqueous phase was transferred into a new tube. The RNA was 
precipitated by adding 0.5 ml of isopropanol. Finally, the pellet was washed twice with 75% 
ethanol and dissolved in 50-100 μl of RNase free water (DEPC-dH2O). The RNA was stored 
at –80°C. 
 
2.2.2 Determination of nucleic acid concentration 
The concentration of nucleic acids was determined spectrophotometrically by 
measuring absorption of the samples at 260 nm. The quality of nucleic acids i.e. 
contamination with salt and protein was checked by the measurements at 230, 280, and 320 
nm. The concentration was calculated according to the formula: 
 
                                        C - (E 260 - E 320)fc 
                                        C = concentration of sample (µg/µl) 
                                           E 260 = ratio of extinction at 260 nm 
                                           E 320 = ratio of extinction at 320 nm   
    f = dilution factor 
    c=  concentration (standard) / absorption (standard) 
    for double stranded DNA : c = 0.05 µg/µl 
    for RNA : c = 0.04 µg/µl 
    for single stranded DNA : c = 0.03 µg/µl 
 
2.2.3 Gel electrophoresis 
2.2.3.1 Agarose gel electrophoresis of DNA 
Agarose gels are used to electrophorese nucleic acid molecules from as small as 100 
bp to more than 50 kb. For preparation of 1% agrose gel, 1 g of agarose was added in 100 ml 
0.5 x TBE buffer, boiled in the microwave to dissolve the agarose, then cooled down to about 
60°C before adding 3 μl ethidium bromide (10 mg/ml). This 1% agarose gel was poured into a 
horizontal gel chamber. 0.5x TBE buffer was used also as electrophoresis buffer. Before 
loading the samples, about 0.1 volume of loading buffer was added and mixed. The samples 
were then loaded into the wells of the gel and electrophoresis was carried out at a steady 
voltage (50 – 100 V). Size of the DNA fragments on agarose gels was determined using 1 kb 
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DNA ladder, which was loaded with samples in parallel slots. DNA fragments were observed 
and photographed under UV light. 
 
2.2.3.2 Agarose gel electrophoresis of RNA  
           (Hodge, 1994) 
Single-stranded RNA molecules often have complementary regions that can form 
secondary structures. Therefore, RNA was run on a denaturing agarose gel that contained 
formaldehyde.  RNA was pre-treated with formaldehyde and formamide to denature. To 
prepare a denaturing agrose gel, 2 g of agarose was added to 20 ml of 10x MOPS buffer and 
148 ml of DEPC water and dissolved by heating in microwave oven. After cooling it to about 
50°C, 33.2 ml of formaldehyde (37%) was added, stirred and poured into a horizontal gel 
chamber. RNA samples were treated as follows: 
10 – 20 μg RNA 
2 μl 10 x MOPS Buffer 
3 μl Formaldehyde 
7 μl Formamide (40%) 
1 μl Ethidium bromide 
5 μl Loading buffer 
Samples were denatured at 65°C for 10 min and chilled on ice before loading into the gel. 
The gel was run at 40 V at 4°C overnight. To determine the size of the nucleic acid fragments 
on agarose gels, molecular weight ladder (0.24 – 9.5 RNA ladder) was loaded with samples in 
parallel slots. 
 
2.2.4 Purification of DNA fragments from agarose gel 
To purify DNA fragments from agarose gel, QIAquick gel extraction kit was used. 
The principle of this method depends on selective binding of DNA to uniquely designed 
silica-gel membranes. After running DNA in the agarose gel, agarose gel piece containing the 
DNA fragment was cut and incubated in 3 volumes of QG buffer at 50 °C for 10 min. Then, 
dissolved gel slice was applied to a QIAquick column and centrifuged for 1 min at 10,000 xg. 
The flow through was discarded and the column was washed with 0.75 ml of PE buffer. After 
drying, the column was placed into a fresh microcentrifuge tube. To elute DNA, 50 μl of 
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2.2.5 Enzymatic modifications of DNA 
2.2.5.1 Digestion of DNA using restriction enzymes 
 
Restriction enzymes are class of bacterial enzymes that recognizes  and cut DNA at 
specific nucleotide sequence of 4 - 8 bp. Restriction enzyme digestions were carried out  by 
incubating double-stranded DNA with an appropriate amount of restriction enzyme in its 
respective buffer as recommended by the supplier, and at the optimal temperature for that 
specific enzyme. Standard digestions include 2-10 U enzyme per microgram of DNA. 
Reactions were usually incubated for 1-3 hrs to ensure complete digestion at the optimal 
temperature for enzyme activity.  
 
2.2.5.2 Ligation of DNA fragments 
 
The ligation of an insert DNA into a vector , which was digested with appropriate 
restriction enzyme, was performed in the following reaction mix: 
                                                           30 ng linearized vector DNA  
                                                           50-100 ng insert DNA  
                                                           1 μl ligation buffer (10x) 
                                                           1 μl T4 DNA ligase (5U / μl) 
                                                             in a total volume of 10 μl 
Blunt-end ligations were carried out at 16°C for overnight, whereas overhang-end ligations 
were carried out at RT for 2-4 hrs. For cloning of PCR products, a pGEMTeasy vector 
system that has 5‘T overhangs was used. The following substances were mixed: 
                                50 ng of pGEMTeasy vector 
                                 150 ng PCR product 
                                 1 μl of T4 DNA Ligase buffer (x10) 
                                 1 μl of T4 DNA Ligase 
The reactions were done in a total volume of 10 μl and incubated overnight at 4°C. 
 
2.2.6 Transformation of competent bacteria 
            (Ausubel et al., 1994) 
            Transformation of the competent E. coli bacteria (invitrogen) was done by gently 
mixing one aliquot of competent bacteria (50 µl) with 10 µl of ligation reaction. After 
incubation for 30 min on ice, bacteria were heat shocked for 45 sec at 40°C and then cooled 
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down for 2 min on ice. After adding 600 µl of S.O.C medium, bacteria were incubated at 
37°C for l hr. Bacteria were plated out either on LB-agar plates containing appropriate 
antibiotic (50 µg/mI) or X-Gal plates. 
 
2.2.7 Polymerase chain reaction (PCR) 
2.2.7.1 PCR amplification of DNA fragments 
The standard PCR assay contained the following components: 
10 ng DNA 
1 μl Forward primer (10pmol) 
1 μl Reverse primer (10pmol) 
1 μl 10mM dNTPs 
5 μl 10x PCR buffer 
1.5 μl 50mM MgCl2 
1 μl Taq DNA polymerase (5U/μl) 
Up to 50 μl H2O 
The reaction mixture was added in a 200 μl reaction tube, vortexed slightly and placed in the 
thermocycler. 
Standard PCR program: 
                   Initial denaturation                                      95°C 5 min 
                   
                    Elongation                                                   95°C 30 sec (denaturation) 
                    30-35 cycles                                                 58°C 45 sec (annealing) 
                                                                                        72°C 1-2 min (extension) 
 
                   Final extension                                               72°C 10 min 
 
2.2.7.2 Genotyping of knockout mice by using PCR 
All offspring of Hsp4a and Hspa41 mutant lines were genotyped by polymerase chain 
reaction (PCR). For amplification of the wild type and the mutant allele, the DNA was 
extracted from mouse tails as described in 2.2.1.2 and pipetted to the following reaction 
mixture: 
0.5 μl DNA (300-500 ng) 
0.5μl Forword primer (10 pmol/μl) 
0.5 μl Reverse primer (10 pmol/μl) 
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0.5 μl Pgk_3 (10 pmol/μl) 
0.5 μl dNTPs (10 mM) 
0.5 μl Taq Platinum buffer (10x) 
0.75 μl MgCl2 (25 mM) 
0.25 μl Taq Platinum  
Up to 25 μl H2O 
The mixture was subjected to the following program in the thermocycler, 
 
Denaturation                                         95°C for 7 min 
 
Elongation 
(for 35 cycle)                                       95°C for 30 sec (Denaturation) 
                                                            58°C for 30 sec (Annealing) 
                                                            72°C for 1 min (Elongation) 
 
Final extension                                    72°C for 10 min 
 
2.2.7.3 Reverse transcription PCR (RT-PCR) 
2.2.7.3.1 DNase I digestion 
RNA samples, which were used in RT-PCR assay, were treated firstly with DNase to 
eliminate the contaminated DNA. The reaction mixture contained the following components: 
 1-5 µg of RNA                                                                              ≤8 µl 
10X DNase I Reaction Buffer                                                        1 µl 
1 µl of DNase I, diluted 1:5                                                            1 µl 
DEPC-treated water                                                                        to 10 µl 
  
 The reaction mixture was incubated for 30 min at 37°C. To inactivate the DNase I,  1 µl of 25 
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2.2.7.3.2 Reverse transcription technique 
To determine the expression of genes in specific tissues or in different development 
stages  RT-PCR assay was performed. 1 -5 µg of total RNA was mixed with 1 µl of oligo 
(dT)  primer (10 pmol/µl) in a total volume of 12 µl. To disrupt the secondary structure of 
the RNA, which might interfere with the cDNA synthesis, the mixture was heated to 65°C 
for 5 min and then quickly chilled on ice. After a brief centrifugation the followings were 
added to the mixture: 
                       4µl 5x First strand buffer 
           2µl 0.1MDT 
           1µl 10 mMdNTPs 
           1µl Rnase inhibitor (10U/µl) 
        The content of the tube was mixed and incubated at 42°C for 2 min. Then, 1µl of 
reverse transcriptase enzyme (Superscript II) was added and further incubated at 42°C for 
50 min for the first strand cDNA synthesis. The reaction was then  inactivated by heating at 
70°C for 15 min. One µl of the first strand reaction was used for the PCR reaction. 
 
2.2.7.4 Quantitive Real-Time PCR  
Extraction of total RNA from tissues was performed using Trifast Reagent as 
described above (2.2.1.3). RNA was treated with DNase I and was then reverse-transcribed 
according to section 2.7.3. Serial dilutions of sample and standard DNA’s were made. To 
generate a standard curve, standard DNA was serially diluted to 20, 10, 5, 2.5, 1.25 and 0.625 
ng/μl, while each RNA sample was diluted to a concentration of 10 ng/μl. To enhance the 
efficiency of PCR amplification, primers were designed to generate amplicons less than 200 
bp. Real-Time quantitative PCR was performed using QuantiTect SYBR Green PCR Master 
mix (Quiagen) in an ABI Prism 7900HT sequence detection system. Each reaction was run in 
triplicate , repeated three times using three animals of each genotype. Levels of mRNA 
expression were normalized to those of the mouse housekeeping genes Sdha (succinate 
dehydrogenase) and Hprt (phophoribosyl-transferase). 5 μl of 2x QuantiTect SYBR-Green 
PCR-Master-Mix, 1 μl Forward Primer (9μM), 1 μl Reverse Primer (9μM), 0.3μl MgCl2 
(50mM) and 1μl of cDNA (in a 1/20 dilution) were mixed with RNase free water to a total 
volume of 10 μl. The following PCR program was used: 
2 min 50°C 
15 min 95°C 
15 sec 95°C 
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30 sec 54°C        40x 
30 sec 72°C 
15 sec 95°C 
15 sec 60°C       Dissociation stage    
15 sec 95°C 
2.2.8 Protein and biochemical methods 
2.2.8.1 Isolation of total protein from mouse tissues 
         100 mg of tissue was homogenized in 500 µl of RIPA buffer containing protease 
inhibitors . Tissues extract was incubated for 30 min at 4°C and then sonicated two times for 
1 min with Branson ultra-Sonifier. The lysates were  centrifuged at 8000xg for 10 min. The 
supernatant containing total proteins was taken and aliquoted in e-cups. The  protein 
samples were stored at -80°C. 
2.2.8.2 Isolation of total protein from cell culture 
 5 x 106 cells/ml were washed with cold phosphate buffered saline (PBS) and 
resuspended in 50 - 200 μl of lysis buffer A. The cell lysate was incubated on ice for 30 min, 
treated with ultrasound on ice two times for 30 sec and centrifuged at 24000 x g for 15 min at 
4oC. The supernatant with protein extract was stored at –80oC . 
 
2.2.8.3 Determination of protein concentration 
           (Bradford, 1976) 
Bio-Rad protein assay was used to determine the protein concentration. The assay is 
based on the observation that the absorbance maximum for an acidic solution of Coomasie 
Blue G-250 shifts from 494 to 595 nm when it is associated to protein. In order to obtain 
standard dilutions in range of 10 μg/ml to 100 μg/ml, BSA stock solution of 1 mg/ml was 
diluted. The dye reagent was diluted 1:5 with H2O and a 2 μl sample was added. The 
absorption of the color reaction was measured at 595 nm in a spectrophotometer. 
    
2.2.8.4 SDS-PAGE gel for separation of proteins 
           (Laemmli,1970) 
NuPage 4-12% Bis-Tris gel ((Invitrogen) was used for separation of  proteins 
according to their molecular weight.  To 15 μl of whole protein lysate, 5 μl of 4 x LDS sample 
buffer and 3 μl of 1 M DTT were added. Then, the samples were denatured in 95oC for 10 min 
and chilled in ice. The gel electrophoresis was run in 1 x MOPS buffer (Invitrogen). As a 
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weight marker, a pre-stained molecular weight standard (See Blue Plus2, Invitrogen) was 
loaded. The gel was  run at 100 V for 2 – 3 hrs at RT. 
 
2.2.9 Blotting techniques 
2.2.9.1 Northern blotting of RNA 
 To transfer the RNA to the nitrocellulose membrane, we used a Turbo-Blot apparatus 
(Schleicher & Schuell, Dassel). About 25-28 Whatman filter papers (GB 003) were layered on 
a Stack Tray, followed by 4 Whatman filter papers (GB 002) and 1 Whatman filter paper (GB 
002), which were soaked with 20 x SSC. The nitrocellulose filter, which was also soaked with 
20 x SSC, was laid on the top. The agarose gel  was placed on the nitrocellulose filter and was 
covered with 3 Whatman filter papers GB 002 soaked with 20 x SSC. The buffer tray was 
filled with 20 x SSC. Then, a wick that was soaked with 20 x SSC, was put on top of the blot. 
The transfer was performed for overnight. Finally, after disassembling of the blot, the RNA 
was fixed onto the filter by baking at 80°C for at least 2 hours. 
 
2.2.9.2 Western blotting of protein 
             (Gershoni and Palade, 1982) 
After electrophoresis of proteins on the SDS-PAGE,   the nitrocellulose membrane   
Hybond-C (Amershan)  was cut at the size of the gel and  soaked with transfer buffer. Four 
pieces of  Whatman filter paper were soaked in transfer buffer and  placed on the semi dry 
transfer machine’s lower plate (Biometra, Göttingen). Then, the wet membrane and the gel 
were put over them. Another four soaked Whatman papers were placed over to complete the 
sandwich model. The upper plate of semi dry transfer machine was placed over this sandwich 
and the transfer was carried out at 10 W (150-250 mA, 39 V) for 1   hr. Next , the 
nitrocellulose membrane was blocked and incubated with antibodies. To assess transfer 
efficiency of proteins onto nitrocellulose membranes, the gel was stained for 30 min in 
Coomassie blue solution at RT. Finally, gel was destainined in Comassie destaining  solution 
for 3-8 hrs at RT. 
 
Transfer buffer    pH 9.2                             5.8 g Tris-HCl 
                                                                    2.9 g Glycine 
                                                                    3.7 ml 10% SDS 
                                                                   dH2O to 1000 ml 
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Membrane staining 
Membrane was stained with Coomassie blue at RT. 
Coomassie blue: 0.1% Coomassie 
                         90% Methanol 
                              10% CH2COOH 
Destaining of the membrane 
Destaining solution: 40% Methanol 
                                   10% CH2COOH 
                 up to H20 
 
2.2.9.3 Incubation of protein –bound membranes with antibodies 
The blotted membrane was first incubated with 5% non-fat milk in PBT for 1-2 hrs at 
RT and then it was incubated overnight at 4 °C with a primary antibody at the recommended 
antibody dilution in 2% non fat milk in PBT. Then, the membrane was washed 3x 20 min 
with 2% non fat milk in PBT and incubated with horse radish peroxidase conjugated seconday 
antibody diluted 1:10000 in PBT containing 2% non fat milk in PBT for 1 hr at RT. After this 
step the membrane was washed 3x for 10 min at RT in PBT with 2% non fat milk in PBT and 
one time for 5 min at RT in PBS.  Finally, the proteins from the membrane were visualized by 
using SuperSignal® West Pico Chemiluminescent Substrate (Pierce, USA) . Membrane was 
incubated for 3-5 min with 1 ml of developing mixture (0.3 ml stable peroxidase solution and 
0.3 ml Luminal/enhancer solution) and then was wrapped in saran foil and exposed to 
Roentgen films (Hyperfilm MP, Amersham, Braunschweig) for 0.5 to 10 min. The films were 
developed in X-Ray Automatic processor Curix . 
 
2.2.10 “Random Prime” method for generation of 32P labeled DNA 
              (Denhardt, 1966; Feinberg and Vogelstein, 1989) 
 
For generation of 32P labeled DNA RediprimeTM II Random Prime Labeling System 
(Amersham Pharmacia) was used. The method depended on the random priming principle 
developed by Feinberg and Vogelstein (1989). Firstly, 25-50 ng DNA were denaturated in a 
total volume of 46 μl at 95oC for 10 min and quickly chilled on ice for 5 min. After pipetting 
the denaturated probe into RediprimeTM II Random Prime Labelling System cup, 4 μl of [α-
32P] dCTP (3000 Ci/mmol) were added to the reaction mixture. The labelling reaction 
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incubated at 37°C for 45 min. The labelled DNA was purified from free [α-32P] dCTP by 
using illustraTMProbe QuantTM G-50 Micro Columns (GE Healthcare). 
 
2.2.11 Hybridisation of nucleic acids 
            (Denhardt, 1966) 
The membrane to be hybridised was equilibrated in 2 x SSC and transferred to a 
hybridisation tube. After adding 12 ml of Rapid-hyb buffer (GE Healthcare) and sheared 
denaturated salmon DNA, the membrane was incubated for 2 hrs in the hybridisation oven at 
65°C. The32P labeled DNA probe was denaturated at 95°C for 10 min, chilled on ice for 5 
min, and added to the hybridisation solution. The hybridisation was carried out overnight in 
the hybridisation oven. The membrane was washed for 10 min with 2 x SSC, and then with 2 
x SSC containing 0.2% SDS at 65°C for 10 – 20 min. Finally, the membrane was washed with 
0.2 x SSC containing 0.1 % SDS at the hybridisation temperature. After drying the filter, it 
was sealed in plastic foil and exposed to autoradiography overnight at -80°C. The film was 
developed in X-Ray Automatic Processor Curix 60. If the membrane has to be used again, it 
was stripped in 0.2 x SSC at 80°C until radioactive signal was no longer detected. 
 
2.2.12 DNA sequencing 
DNA sequencings was performed with the Dye Terminator Cycle Sequencing-Kit 
(ABI PRISM). The reaction products were analysed with automatic sequencing equipment, 
MegaBase DNA Sequencer. For the sequencing reaction, four different dye labelled dideoxy 
nucleotides were used (Sanger et al., 1977), which, when exposed to an argon laser, emit 
fluorescent light that can be detected and interpreted. 
The reaction was carried out in a total volume of 10 μl containing 1 μg plasmid DNA 
or 100-200 ng purified PCR products, 10 pmol primer and 4 μl reaction mix (contained 
dNTPs, dideoxy dye terminators and Taq DNA polymerase). Elongation and chain 
termination took place during the following program in a thermocycler: 4 min denaturation 
followed by 25 cycles at 95°C, 30 sec; 55°C, 15 sec, annealing; 60°C, 4 min, elongation. 
After the sequencing reaction, the DNA was precipitated with 1/10 volume 3 M sodium 
acetate and 2.5 volume 100% ethanol and washed in 70% ethanol. The pellet was dissolved in 
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2.2.13 Histological techniques 
2.2.13.1 Tissue preparation for paraffin-embedding 
Tissues were isolated from mice and fixed in Bouin’s solution or 4% (w/v) 
paraformaldehyde for 6 - 24 hrs to prevent alterations in the cellular structure. The 
dehydration process was accomplished by passing the tissues through a series of increasing 
alcohol concentrations, i.e. 70%, 80%, 90%, 96%, 100% ethanol for 1 hr at RT and 
isopropanol overnight. The alcohol was removed from the tissues by incubation in 25%, 50%, 
75% and 100% xylene. Tissues were then incubated in paraffin at 60°C for 12-24 hrs. The 
paraffin was changed at least three times. Finally, tissue was placed in embedding mold and 
melted paraffin was poured into the mold to form a block. The paraffin block was cooled at 
4°C. 
 
2.2.13.2 Sections of the paraffin block 
Paraffin blocks were clamped into the microtome (Hn 40 Ing., Nut hole, Germany). 
The thickness of the sections was 5-7 μm. The sections were floated on 40°C water to allow 
actual spread. Then, they were put onto slides. After complete drying at 37°C, slides were 
stored at 4°C for further analysis. 
 
2.2.13.3 Immunofluorescence staining  
Tissue cross sections were incubated twice for 10 min in xylene to remove the 
paraffin. Then, they were rehydrated by descending ethanol concentrations. For 
immunofluorescence staining, sections were placed into a plastic staining dish containing the 
antigen retrieval buffer . This plastic staining dish was placed into boiling water bath for 15 
min and then placed in ice for 10 min. Then slides were  incubated with a blocking solution 
containing 10% goat  or sheep serum in 0.02% Tween-20 in PBS for 2 hrs at RT. Slides were 
then incubated with primary antibodies for overnight in a humidified chamber at 4°C. 
Subsequently, they were rinsed three times for 5 min in PBS and incubated with secondary 
antibody for 1 hr. Finally, the slides were washed three times for 5 min in PBS and the nuclei 
were counterstained with DAPI. Immunostaining of the sections was examined using a 
fluorescence equipped microscope (BX60; Olympus). When alkaline phosphatase secondary 
antibody was used , immunostaing was detected by adding  alkaline phosphatase substrate 
(Fast Red TR/Naphthol AS-MX®, Sigma) to the sections for 15 min. To stop the reaction, the 
slides were immersed in Copling jars filled with distilled water, slides were then covered with 
Aqua-Poly-Mount.   
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Antigen retrieval buffer:   
Sodium Citrate Buffer (10mM Sodium Citrate, 0.05% Tween 20, pH 6.0) 
 
2.2.13.4 Immuncytochemical staining of germ cell suspension 
Germ cell suspension was prepared from mouse testes by using the collagenase/trypsin 
method according to published procedure (Romrell et al., 1976). Testes from 60 days old 
mice were collected in serum-free culture medium, rinsed in 0.1 M PBS, pH 7.2. After 
removal of the tunica albuginea, seminiferous tubules were enzymatically dissociated by the 
addition of 1ml collagenase (1mg/ml). The slurry maintained at 37°C for 30 min was 
triturated every 5 min. 5 ml of Hank’s solution was added and then spun at 500 xg to sediment 
the dissociated cells. The pellet was resuspended in 3 ml trypsin, incubated for 5 min and then 
trypsin (0.5 mg/ml) was inactivated by  adding 2 ml FKS. The slurry was passed through 
80µm nylon mesh. The filtrate was spun at 500 xg to sediment the cells. Cells were 
resuspended in PBS and spread onto superfrost slides, air-dried and fixed in 4% PFA for 10 
min at RT. Next, they were washed twice in PBS and immunostained as described above 
(2.2.13.3). 
 
2.2.13.5 Hematoxylin-eosin (H&E) staining of histological sections 
Histological sections were incubated three times in xylene for 3 min each, followed by 
incubation in 100% for 3 min, 95% and 80% ethanol for 2 min each.  Slides were then washed 
in dH2O for 5 min and stained for 3 min in hematoxylin. The staining was followed by rinsing 
with deionised water and washing in tap water for 10 min. Slides were dipped in acid ethanol 
(1ml concentrated HCl in 400 ml 70% ethanol) for 8-12 times to destain , then in amonium 
water (0,25%), rinsed in tap water for 2 min and in deionised water for 2 min. Thereafter 
slides were stained with eosin (0.1% + 2% acetic acid) for 1 min, then in dH2O for 1 min and 
incubated in 50%, 70%, 80%, 90%, 96% and 100% ethanol for 2 min in each. Finally they 
were incubated two times in histoclear (Xylol) for 5 min and mounted with Eukitt-quick 
hardening mounting medium. 
 
 
2.2.13.6 Apoptosis detection 
The slides containing the thin (5 µm ) sections of testis were processed for a TUNEL 
assay to assess the possible number of cells undergoing apoptosis by an ApopTag detection 
kit. The sections were firstly deparafinized, hydrated and washed 2 x 5 min in PBS. Slides 
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were then incubated for 15 min at RT in 20 μg/ml Proteinase K and washed 2 x 2 min in 
dH2O. To block endogenous peroxidase, tissues were incubated in 3 % H2O2 for 5 min at RT. 
After 2 x 5 min washing in PBS, the tissues were covered for 10 sec with equilibration buffer. 
Slides were incubated with Working Strength TdT Enzyme (30% enzyme in reaction buffer) 
for 1 hr at 37oC in darkness. Slides were incubated for 10 min shaking at RT in Stop/Wash 
buffer (1:34 in dH2O) , washed 3 x 1 min with PBS. Thereafter, slides were incubated with 
anti-digoxigenin for 30 min at RT in darkness and then washed 4 x 2 min with PBS. Slides 
were stained with Working Strength Peroxidase Substrate (2% DAB Substrate in DAB 
Dilution buffer) for 6 min at RT, washed 3 x 1 min and 1 x 5 min with dH2O. Finally, slides 
were covered by AquaPolyMount liquid. . The percentage of cell death was determined by 
counting the cells exhibiting brown nuclei (TUNEL-positive) and compared with cells from  
wildtype littermate. 
 
2.2.14 Masson's Trichrome staining 
Masson's Trichrome stain identifies nuclei in black, cytoplasm , keratin and muscle 
fibers in red, and collagen, mucin  in blue. Trichome stains are used primarily for 
distinguishing collagen from muscle tissue. Accustain trichome stains (Masson) from Sigma-
Aldrich was used. Heart and skeletal muscle sections were stained with Masson's Trichrome 
stain to identify any fibrotic areas. Briefly , slides were deparaffinized and rehydrated before 
placing in Bouin's fixative overnight at RT. Slides were placed in Working Weigert's Iron 
Hematoxylin solution for 5 min , rinsed in running tap water for 10 min , placed in Beibrich 
scarlet-acid fuchsin solution for 5 min and  then rinsed until clear. Next, slides were immersed 
in phosphomolybdic-phosphotungstic acid solution for 5 min , followed by aniline blue 
solution for 5 min, rinsed and then placed in 1% acetic water for 2 min. Finally, rinsed slides 
were dehydrated and protected with Eukitt-quick hardening mounting medium. 
 
 
2.2.15 Tissue preparation for electron microscopy 
The left ventricle of freshly isolated heart was cut in small pieces and  treated with 
fixation solution for 8-12 hrs in 4°C. Tissues were then washed in washing buffer for a few 
hours and sent to Dr. C. Mühlfed (Department of Anatomy and Cell Biology, University of 
Giessen), who did the electron microscopy analysis. 
Fixation solution: 1% Paraformaldehyde 
                             3% Glutaraldehyde 
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                             In 0.1 M Cacodylat buffer, pH 7.4 
Washing solution 3.4 % Saccharose 
                            in 0.1 M Cacodylat buffer, pH 7.4 
 
2.2.16 Echocardiogram 
Echocardiographic assessments were done in collaboration with Prof. Dr.  Maier, 
Deptartement of Cardiology and Pneumology, Göttingen University.  Echocardiography was 
performed on a Toshiba Power Vision 6000 system with a 15-MHz ultrasound probe under 
general anesthesia with tribromoethanol/amylene hydrate (Avertin; 2.5% wt/vol, 6 _L/g body 
weight i.p.) under spontaneous respiration (Natalie. et al., 2007).  
 
2.2.17 Microarray analysis 
  Microarray analysis was performed at the Göttingen Transcriptome Analysis 
Laboratory, Medical Faculty, University of Göttingen  .  RNA was isolated from heart as 
described in 2.2.1.3. 0.3 µg of total RNA were used as a starting material to prepare cDNA. 
The synthesis of double-stranded cDNA was done with the WT Target Labeling and Control 
Reagents (Affymetrix; Cat. N° 900652). The cleanup of double-stranded cDNAwas done 
using the GeneChip® Sample Cleanup module (Affymetrix).The in-vitro transcription was 
conducted with the WT Target Labeling Kit (Affymetrix). The total amount of the reaction 
product was purified with the GeneChip® cRNA Samle Cleanup Module (Affymetrix) and 
quantified using the NanoDrop ND-1000. A cDNA synthesis (ss) were performed using the 
WT Target Labeling Kit (Affymetrix). 5.5 µg of ssDNA were cleaved into fragments of 35-
200 bases by enzymatic processes. The degree of fragmentation and the length distribution of 
the ssDNA were checked by capillary electrophoresis using the Agilent 2100 Bioanalyzer. A 
terminal labeling reaction (Biotin) was performed after fragmentation using the WT Labeling 
Kit ( Affymetrix; Cat. N° 900652). Biotinylated fragmented ssDNA was hybridized onto the 
GeneChip® Mouse Gene 1.0 ST Array (Affymetrix; Cat. N°901171) according to the 
manufacturer’s recommendation. The hybridization were performed for 16 hrs at 60 rpm and 
45°C in the GeneChip® Hybridization Oven 640 (Affymetrix). Washing and staining of the 
arrays were done on the Gene Chip® Fluidics Station 450 (Affymetrix) according to the 
manufacturers recommendation. The antibody signal amplification, washing and staining 
protocol were used to stain the arrays with streptavidin R-phycoerythrin (SAPE; Invitrogen, 
USA). To amplify staining, SAPE solution were added twice with a biotinylated anti-
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streptavidin antibody (Vector Laboratories, CA) staining step in between. Arrays were 
scanned using the GeneChip® Scanner 30007G. 
 
2.2.18 Computer analysis 
For the analysis of the nucleotide sequences, programs like BLAST, BLAST2, 
MEGABLAST and other programs from National Center for Biotechnology Information 
(NCBI) were used (www.ncbi.nlm.nih.gov). For protein studies ExPASy tools 
(www.expasy.ch) were used. Mouse genome sequence and other analysis on mouse genes, 













3.1 Analysis of Hspa4- deficient mice on the hybrid C57BL/6J x 129/SV  genetic background 
Analysis of Hspa4-deficient mice in hybrid C57BL/6J x 129/SV genetic background 
showed that male infertility is the most apparent phenotype. However, the fertility was 
heterogeneous in male. Thus, 8 of 13 male mutants did not produce a single litter, whereas the 
remaining 5 males produced litter size similar to that of wild type males. Histological analysis of 
testes from adult Hspa4- deficient mice revealed that the disruption of spermatogenesis is the 
main cause of male infertility (Held, 2008).  
 
3.1.1 Impaired progression of the first wave of spermatogenesis in juvenile Hspa4-deficient 
mice 
 To identify the spermatogenic stage at which spermatogenesis is affected by Hspa4-
deficiency, testicular sections from different postnatal days (P5, P10, P15, P20 and P25) were 
stained with hematoxylin and eosin. Histological analysis of 5-day-old Hspa4-/- testis showed 
normally developed Sertoli cells and  gonocytes at the basement membrane of seminiferous 
tubules (Fig. 3.1A, B). In wild-type testis, at postnatal day 10 spermatogonia proliferate and 
develop to primary spermatocytes. No apparent differences were found in histological structure of 
seminiferous tubules between wild type and mutant mice at postnatal days 5 and 10 (Fig.3.1A-D 
). These results suggest that the proliferation and differentiation of spermatogonia to primary 
spermatocytes did not require Hspa4, despite the high expression of Hspa4 in gonocytes (Held, 
2008). At postnatal day 15, when spermatogenesis progresses to mid-and late pachytene 
spermatocytes in wild-type testis (Fig. 3.2A), the number of pachytene spermatocytes was found 
to be drastically reduced in Hspa4-deficient testes (Fig. 3.2B). By postnatal day 20, 
spermatogenesis has reached the stage of round spermatids in wild-type tubules (Fig.3.2C). In 
contrast, mutant tubules are almost completely devoid of round spermatids and contain a reduced 
number of pachytene spermatocytes (Fig. 3.2D). At day 25, when tubules of wild-type littermates 
showed elongated spermatids as most advanced germ cells (Fig. 3.2E), Hspa4-/- testis showed 
severe depletion of germ cells. Very few seminiferous tubules contained round spermatids as 

























Fig.3.1. Histological analysis of testes from 5- and 10- day-old wild type (+/+) and Hsp4a- 
deficient mice (-/-) reveals normal histological structure of seminiferous tubules. (A, B) 5-day- 
old testis (C, D) 10-day- old testis. Sp –primary spermatocytes... Photos were taken in 20 x 
magnification. 
 
These results suggest that spermatogenesis in Hspa4-/- testis is arrested at first meiotic prophase. 
 
3.1.2 Immunohistochemical analysis of Hspa4-/- testes 
 To confirm the results of histological analysis, we performed immunohistochemical 
analysis using different germ cell markers. Using the anti-heat shock protein 110 (HSPH1) 
antibody to label gonocytes (Held, 2008), the Hspa4+/+ and Hspa4-/- tubules contained an 




impair the gonocytes. Using anti-germ cell nuclear antigen 1 (GCNA) antibody, which recognizes 
the spermatogonia and primary spermatocytes (Enders and May, 1994),  the number of 
spermatogonia per tubule was not significant different between 5-day-old wild-type and mutant 
testis (Fig. 3.3D-F). This result suggests that the differention of gonocytes to spermatogonia is 
not affected in 5-day-old Hspa4-/- testis. In wild type testis, at postnatal day 10 spermatogonia 
underwent mitotic division and differentiate to spermatocytes. The mean number of GCNA1-
positive germ cells in mutant and wild-type tubules was not significantly different at postnatal 
day 10, suggesting that mitotic division in mutant testes is not affected (Fig. 3.3G-I). However, 
few seminiferous tubules of Hspa-/- testes lacked meiotic germ cells (pachytene spermatocytes) at 
postnatal day 15. By immunohistological staining for heat shock protein 4- like ( HSPA4L) 
protein, which is highly expressed  in pachytene spermatocytes (Held et al., 2006), a reduction 
was observed in the mean number of HSPA4L-immunopositive cells per tubule  in testis of 
Hspa4-/- mice compared to wild-type mice (Fig.3.4A-C). Such reduction of HSPA4L-
immunopositive cells was also observed in 20-day-old Hspa-/- testis (Fig. 3.4D-H). To prove 
whether the arrest of meiotic division is due to defects in pairing of homologous chromosomes 
during prophase I, we examined chromosomal synapses in Hspa4-/- spermatocytes. Germ cell 
suspension was prepared from adult wild-type and mutant testes, spread on slides, fixed with 
paraformaldehyde and immunostained with an antibody against synaptonemal complex protein 3 
(SYCP3). The SYCP3 is a part of the synaptonemal complex between synapsed chromosomes 
during pachytene and remains on the disynapsed axis during diplotene.  Analysis of germ cell 
spreads revealed that the formation of synaptonemal complexes in the meiotic cells of mutant 
testis was indistinguishable from that in wild-type. This indicates the proper accumulation of the 

































Fig. 3.2. Delayed and disrupted first wave of spermatogenesis in Hspa4 mutant mice. Testicular 
sections from wild-type and Hspa4-null mice of various postnatal days (P) were stained with 
H&E. At P15, spermatogenesis has progressed up to pachytene spermatocyte stage (black 
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arrowhead) in wild-type mice (A), whereas very few pachytene spermatocytes are present in 
testes of mutant mice (B). At P20, spermatogenesis reached the stage of round spermatids 
(arrow) in wild-type mice (C), whereas germ cell development in Hspa4-null mice is mostly 
impaired, seminiferous tubules are filled with premeiotic germ cells (white arrowhead) and 
contain very few pachytene spermatocytes. At P25, spermatogenesis is progressed to stages of 
round and elongated spermatids in wild-type tubules (E). In contrast, meiotic germ cells are 
















Fig. 3. 3.  Expression profile of premeiotic and meiotic markers in  Hspa4+/+ and Hspa4-/- testes. 
Histological sections of wild-type (A, D and G) and null-mice (B, E, I) at different postnatal days 
(P5 and P10) were immunostained with HSPH1 ( A, B ) and GCNA1 (D E, G, H) antibodies. No 
significant difference is observed in the mean number of HSPH1- (C) and GCNA1-positive cell at 















Fig. 3.4. Expression of HSPA4L in  Hspa4+/+ and Hspa4-/- testes. Histological sections of wild-
type (A, B) and null-mice (D, E) at different postnatal days (P15 and P20) were immunostained 
with HSPA4L antibody. A significant reduction in the mean number of HSPA4L-positive cells per 
















Fig. 3.5   . Immunofluorescent localization of SYCP3 on synaptonemal complexes of wild-type ( 
A-C) and Hspa4-deficient (D-L) pachytene spermatocytes . Representive sections were obtained 
from 5-month old Hspa4-/- and WT. Cells stained with anti-SYCP3 (Red) and DAPI (blue). 60 fold 
magnification. 
 
3.1.3 Increase of apoptotic germ cells in Hspa4-/- testes 
 To determine whether the observed  absence of differentiated germ cells is the result of 
enhanced apoptosis in Hspa4-null mice, TUNEL assay was performed to identify apoptotic cells 
during first wave of spermatogenesis in testes of postnatal day 10, 15, 20 and 25 (Fig. 3.6A-H ). 
There are no significant differences in the number of apoptotic cells between Hspa4-/- and 
Hspa4+/+ testes at P10 (Fig. 3.6A, B and Fig. 3.7). A significant increase of TUNEL-positive 
spermatocytes was found in Hspa4-null mice at P15, 20 and 25 (Fig.3.6 D- H and Fig. 3.7).  The 
frequency of TUNEL-positive cells was variable among tubules, but overall there were 
significantly more apoptotic cells in the seminiferous tubules of infertile Hspa4–/– mice than in 






Most of TUNEL -positive cells were seen to be in meiotic prophase (Fig.3.6 D- H). These results 
indicate that germ cells at meiotic stages appear to be the most affected cells in Hspa4-deficient 
testes.  
 
3.1.4 Expression analysis of germ cell marker genes in Hspa4-deficient testes 
To further identify the spermatogenic stage at which spermatogenesis is impaired in adult 
Hspa4-null mice, we analysed the expression of different meiotic and postmeiotic marker genes. 
Testicular RNA was isolated from 5-month old wild type, fertile and infertile Hspa4-/- mice, and 
probed subsequently with a cDNA probe for Sycp3, Pkg2, Acr, Hsc70t and Tnp2 genes.  The 
amount of loaded RNA used in this experiment were proved by rehybridization  of blots with a 
cDNA probe for β-actin (Fig. 3.8A). Expression of Sycp3 gene encoding synaptonemal complex 
protein-3, which is exclusively expressed in leptotene and zygotene spermatocytes, revealed that 
the expression levels of Sycp3 in testes of fertile and infertile Hspa4-/- mice are similar with that 
in wild-type testes. In contrast, expression of testis-specific phosphoglycerate kinase gene (Pgk2) 
and acrosin (Acr), which were reported to peak in pachytene spermatocytes, was significantly 
reduced in testes of infertile Hspa4-null mice. Similar results were also shown for the transcript 
level of postmeiotic-specific genes Hsc70t (Hsp70 homolog gene) and Tnp2 (transition nuclear 
protein 2). These results confirm that the spermatogenic arrest in Hspa4-deficient mice occurred 
late in meiotic prophase I. 
 
3.1.5 Expression analysis of other members of HSP110 family in Hspa4-/- testis 
  The leaky phenotype in spermatogenesis of Hspa4-null mice may be due compensation by 
overexpression of other members of HSP110 family. Therefore, we analysed the expression of 
HSPA4L and HSPH1 in testes of fertile Hspa4-/- mice (Fig. 3.8B). Western blot analysis did not 
reveal a marked increase in the expression of HSPA4L and HSPH1 in testes of Hspa4-null mice. 
These results suggest that the deficient of HSPA4 expression in the testes is not compensate for 



























Fig. 3.6. Enhanced apoptosis during germ cell differentiation of Hspa4-null mice. Histological 
sections of Hspa4+/+ (A, B, E and G) and Hspa4-/- mice (B, D, F and H) at different postnatal days 
(P) were subjected to TUNEL staining. The proportion of TUNEL-stained apoptotic cells (brown 
nuclei) at P15, P20 and P25 is higher in testes of Hspa4-deficient than in testes of wild-type 
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mice. Apoptotic germ cells are mainly pachytene spermatocytes as indicated by their nuclear size 













Fig.3. 7. Quantification of TUNEL –positive germ cells in Hspa4- deficient mice and wild type 
mice at different postnatal days(P10, P15, P20 and P25)  . Mean (± SEM) number of apoptotic 




























Fig. 3.8. Expression profile of different germ cell markers and members of HSP110 family in 
Hspa4-/- testes. (A) Northern blot with total RNA from testes of Hspa4+/+ (+/+), fertile (-/-F) and 
infertile Hspa4-/- (-/-IF) mice was sequentially hybridized with cDNA probes for the indicated 
genes. (B) Expression pattern of other members of the HSP110 family in testes of wild-type and 















3.2   Hspa4-deficient mice with the inbred 129/Sv genetic background display postnatal 
growth retardation 
In contrast to the Hspa4 deficiency in the hybrid C57BL/6J x 129/Sv genetic background , 
analysis of Hspa4-deficient mice with the inbred 129/Sv genetic background revealed that 85% of 
Hspa4-deficient mice display growth retardation and 94,1% of newborn animals died between the 
third and fourth week after birth (Held, 2008). The cause of postnatal growth retardation shown in 
Hspa4-deficient mice could be due either to: 
1- Metabolic failure or malabsorption of nutrients in the intestine   
 2- Defect in growth hormone (GH)-signaling 
  3- Increased degeneration of skeletal muscle and/or failure in muscle regeneration 
Several experiments are performed to differentiate between these possible causes. 
 
3.2.1 Metabolic state in Hspa4-deficient mice 
3.2.1.1 Measurement of glucose levels in sera of Hspa4-deficient mice 
 To determine whether growth retardation in Hspa4-deficient mice is due to impaired 
glucose homeostasis, we have determined the glucose levels in serum of 10-, 15-, (22-28) and 60-
day-old wild-type and mutant mice. The presence of milk food in the stomach of mutant neonatal 
animals was also monitored. Blood glucose concentrations in 10-, 15-and 20-day-old Hspa4-/- 
mice were significantly lower than in control littermates (Fig. 3.9). Dissection of mutants at these 
postnatal stages revealed that these mice had milk in their stomach. Although these mutant mice 
have lower glucose levels, they did not suffer with hypoglycemia, which is characterized by 
decrease of glucose levels in blood to less than 60 mg/dl. In contrast to their siblings, all the 
mutant mice (between 22- to 28-day-old) had less or no food in their stomachs and their glucose 
levels were decreased to 56±17.3 mg/dl (Fig. 3.9). Blood glucose concentrations in adult mutants, 
which had overcome the neonatal lethality, were not significantly different from those of wild-
type. These results suggest that the growth retardation shown in Hspa4-/- animals during postnatal  
life is not due to hypoglycemia. Hypoglycemia found in Hspa4-/- animals at age between 22 to 28 
















Fig. 3.9. Glucose levels in the blood of   Hspa4-/- and Hspa4+/+ mice at different postnatal stages. 
Blood glucose was determined in the tail veins of 10-, 15-, 20-, (22-28)-, and 60 day-old mice. 
The glucose levels are significantly lower in Hspa4-deficient mice at different postnatal stages. In 
contrast, adult mutants have normal glucose level. Data are presented as mean ±SD of at least 4 
animals of each age; *, p<0.05, **, p<0.001. 
 
3.2.1.2 Expression of Pepck in liver of fasted  Hspa4 -/- mice 
    The gluconeogenesis is the main source of liver glucose output upon long term fasting. 
There are several enzymes which are involved in gluconeogenesis (Irimia, et al. 2010). To 
determine whether the hypoglycemia found in Hspa4-/- mice is a result of impaired 
gluconeogenesis, four mutants and three wild-type mice were fasted for 24 hrs and glucose 
concentrations in their blood were measured before and after fasting. Total RNA was isolated 
from the liver of fasting animals and used to determine the expression profile of 
phosphoenolpyruvate carboxykinase (Pepck), which is a key enzyme of gluconeogenesis in liver 
(Rajas et al., 2000). In contrast to the fed animals, the glucose levels in blood of fasted Hspa4-/-   
mice were significantly lower than in of their control littermates (Fig. 3.10A and B). Northern 
blot analysis revealed that the expression of Pepck is not downregulated in liver of mutant mice 
(Fig. 3.10C). These results suggest that hypoglycemia showed in fasted Hspa4-/- is not due to 
















Fig. 3.10. (A, B) Glucose levels were measured in blood of 2-month-old wild-type (n=3) and 
Hspa4-/- (n=4) animals before (A) and after fasting (B). Data are presented as mean ±SD; *, 
p<0.05. Northern blot with RNA isolated from liver of these fasted animals was hybridized with a 
Pepck cDNA probe (C).  Blot was rehybridized with β-actin to determine the integrity and equal 
amount of  RNA loading (C). 
 
3.2.2   Is  growth retardation  due to malabsorbtion of lipids in intestine? 
 The decrease of glucose levels in blood despite the presence of normal amount of milk 
and food in stomach of Hspa4-/- mice at age 10- to 25-day lead us to determine whether their 
growth retardation may be a result of malabsorbtion of lipids in the intestine. In newborn mice, 
dietary fat is absorbed in intestine, predominantly as triacylglycerol (TG). In the endoplasmic 
reticulum of enterocytes, the lipoproteins are assembled in chylomicrons, which transport the 
lipids to peripheral tissues. The assembly of these chylomicrons by intestinal epithelial cells is 
dependent on the presence of microsomal triglyceride transfer protein (MTP) and apolipoprotein 
B (ApoB) and apolipoprotein AIV (apoAIV). The B apolipoproteins, apo48 and apoB100, play 
important structural roles in the formation of lipoproteins in intestine and liver. In the intestine, 
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the microsomal triglyceride transfer protein (MTT) transfer triglyceride to ApoB and apoAIV 
proteins (Black, 2007). 
 
3.2.3 Expression analysis of apolipoprotein B and AIV in intestine and liver during postnatal 
development of Hspa4-/- mice 
  To determine whether the growth retardation in Hspa4-/- mice is due to a defect in 
lipid absorption, expression of apoB and apoAIV was determined in liver and intestine of 10-, 15-
, 20- and 25-day-old Hspa4+/+ and Hspa4-/- mice. As shown in figure 11A and B, no difference 
between wild-type and Hspa4-/- mice was found in expression of ApoB in liver and intestine (10- 
and 15-day-old mice). Similar results were obtained for ApoAIV in intestine of both genotypes at 
these postnatal stages (Fig. 3.11A, B). Apo AIV is not expressed in liver of 10- and 15-day-old 
Hspa4+/+ and Hspa4-/- mice. In contrast, overexpression of ApoB was found in  liver and intestine 
of 20- and 25-day-old  Hspa4-/- mice, compared to that of wild-type. Expression of apoAIV was 
also found upregulated in Hspa4-/- intestine of both ages (Fig. 3.11C, D). At postnatal day 20, 
expression of Apo AIV was higher in intestine of Hspa4-/- than in that of Hspa4+/+ mice, while no 
expression of Apo AIV could be detected in 20-day-old liver of both genotypes (Fig. 3.11C).  
Expression of ApoAIV in liver of 25-day-old Hspa4-/- mice was higher than in  Hspa4+/+liver 
(Fig. 3.11D). These results revealed that the ApoB gene is upregulated in intestine and liver of  
Hspa4-/- mice at postnatal day 20 and 25-day, while the levels of ApoAIV mRNA are higher in 
20- and 25-day-old Hspa4-/- mice in intestine. 
 
3.2.4 Growth hormone (GH) signaling  is not affected in Hspa4-/- mice  
It is known that postnatal growth, such as muscle and longitudinal growth, is mediated by 
growth hormone (GH) signaling. Furthermore, several lines of evidence reveal the crucial role of 
the hepatic glucocorticoid receptor (GR) to modulate the large set of GH-responsive genes 
(Tronche et al., 2004; Engblom et al., 2007).  To determine whether the growth retardation of 
Hspa4 -/- mice is due to defect in GH-signaling, we analyzed   the expression of two GH- 
responsive genes, Amyloid P component (APCS) and solute carrier organic anion transporter 
family, member 1b2 ( SLCO1B2) (Lin et al., 2008), in liver of wild-type and Hspa4-/- animals 
(Fig. 3.12) . Northern blots with RNA isolated from 10- and 14-day-old wild-type and Hspa4-/- 
were hybridized with APCS and SLCO1B2 cDNA probe. The results of Northern blot show that 
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there are no differences in expression of APCS and SLCO1B2 in liver of Hspa4 -/- and wild-type 


















Fig.3.11. Expression analysis of apolipoprotein B (apoB) and apolipoprotein A4(apoAIV) 
during the postnatal development of  Hspa4+/+ and Hspa4-/- mice .  Total RNA was extracted 
from liver and intestine at different postnatal developmental stages. Northern blots with total 
RNA from liver and intestine of 10- (A), 15- (B), 20 (C)- and 25- (D) day-old Hspa4+/+ and 
Hspa4-/-  mice were hybridized with ApoB and ApoAIV cDNA probes. The blots were 















Fig. 3.12. Expression  analysis of GH- responsive genes in Hspa4-deficient and wild-type liver. 
Total RNA was extracted from 10- and 14-day-old Hspa4+/+ and Hspa4-/-   liver and subjected to 
Northern blots hybridization using the Amyloid P component (APCS) and the solute carrier 
organic anion transporter ( SLCO1B2) cDNA probe, respectively. For RNA quality control 
Northern blots were rehybridized with mouse β –actin. 
 











3.2.5 Analysis of skeletal muscles of  Hspa4- deficient mice. 
3.2.5.1 Hspa4-deficient mice display skeletal muscle myopathy 
The presence of kyphosis in Hspa4–deficient mice of advanced age and reduction of 
skeletal muscle mass in Hspa4–deficient mice compared with wild-type lead us to suggest that 
the skeletal muscle of  Hspa4-/- mice is affected. In order to determine the effect of Hspa4 
deficiency on skeletal muscle, histological analysis of different skeletal muscles was performed. 
Tibialis anterior, Vastus intermedius, Soleus and diaphragm muscles were isolated from 4-month-
old Hspa4-deficient and wild-type mice, fixed in Bouin solution and embedded in paraffin. 
Analysis of hematoxylin & eosin stained sections of Soleus muscle revealed clear differences 
between wild-type and Hspa4-deficient mice (Fig. 3.13 A-D). Soleus muscle of mutant mice 
displayed severe myopathic changes. The myopathic changes are characterized by a marked 
variation in myofibrer size, percentage of muscle fibers with central nuclei, which represent 
regenerated muscle fibers, and accumulation of nuclei representing necrotic fibers (Fig. 13B and 
D). Vastius intermedius (Fig.3.13F and H) and Tibialis anterior (Fig 3.13 J and L) also displayed 
myopathic changes. No myofibers with centrally located nuclei and variation in size of myofibers 
was detected in the diaphragm muscle of Hspa4-/- mice at 4-month of age (data not shown). To 
determine whether the skeletal muscle myopathy represents the major cause for observed 
kyphosis in Hspa4-/- mice of advancing age, histological analysis of paraspinal muscle of  18-
month-old wild type and Hspa4 -/- mice was performed and an abundant pathology was found 
(Fig. 3.14A-G). These results suggest that myopathy of the paraspinal muscle is a cause of 
kyphose development in aging Hspa4 -/- mice. 
 
3.2.5.2 Skeletal muscle myopathy develops during early postnatal development 
The growth retardation of Hspa4 -/- mice was observed after postnatal day 10. Therefore, 
histological sections of the Soleus muscle of 13- and 19-day-old wild-type and Hspa4 -/-  mice 
were analyzed (Fig 3.15A-F). Careful analysis of cross-section areas showed a significant 
increase in the percentage of myofibers with central nuclei in 13-day-old Soleus muscle of Hspa4 
-/- mice compared to wild-type (Fig.3.15C). The decrease of fiber size and the presence of 
myofibers with central nuclei are associated with skeletal muscle myopathy (Buj-Bello et al., 
2008; Guo et al., 2006;  Joya et al., 2004). This result further support that the growth retardation 
in Hspa4-/- mice is a result of myopathy of skeletal muscle. Similar muscle histopathology was 
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shown with histological sections in the Soleus muscle from 19-day-old Hspa4 -/-   and wild-type 
mice (Fig. 3.15D-F).  
 



















Fig. 3.13 . Histological evidence of myopathy in 4-month-old Hspa4-/-  mice. Histological sections 
of a region of Soleus (A-D), Vastius intermedus (E-H) and Tibialis anterior (I-L) muscles of 4-
month-old wild-type (+/+) and mutant (-/-)mice. The boxed areas in B, F, J are shown in higher 
magnification in D, H and L. The white arrows and white head arrows indicate fibers with 
centrally located nuclei and accumulation of nuclei, respectively. In the boxed area show also the 
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variation in myofiber size. Sections were photographed at 20x (A, B, E, F, I, J) and at 60x (B box 





















Fig.3.14. Myopathy in the paraspinal muscle is a cause of kyphosis in Hspa4-/- mice. (A) 
Development of kyphosis in 18-month-old Hspa4-/- mice. H&E-stained section from paraspinal 
muscle of wild-type (+/+) and mutant mice (-/-) at 18-months of age.  Myofibers with central 
















Fig. 3.15. Histological studies of 13- (A-C) and 19-day-old (D-E) muscle in Hspa4-mutant (-/-) 
and wild type (+/+). (B and E) Sections of skeletal muscle from Hspa4-mutant mice showed 
marked increase of myofibers with central nuclei (white arrows) compared to control. Histogram 
comparing the percentage of fibers with centrally located nuclei in Soleus from 13- (C) and 19-





















3.2.6 Analysis of the heart in Hspa4-deficient mice  
 
3.2.6.1 Development of cardiac hypertrophy in Hspa4-deficient mice 
 To determine whether myopathy of skeletal muscle is also realized in heart as 
hypertrophic cardiomyopathy, we analyzed hearts from 12-month-old wild-type and Hspa4-
mutant mice. Heart showed marked enlargement in comparison to that of wild-type control (Fig. 
3.16A). Histological examination revealed prominent myocyte degeneration and loss and 
intracellular vacuoles in cardiomyocytes surrounded by fibrotic tissue (Fig. 3.16B, C). This 
histopathalogy are features of sustained hypertrophy. To confirm that loss of myocytes is 
accompanied by extensive fibrosis, heart sections were stained with Massion's trichome staining. 
As shown in figure 3.16A and D, the increase of Hspa4-/- heart size is consistent with the 
thickened interaventricular septum and ventricular wall and decreased left ventricular cavity size. 
Significant levels of fibrosis are indicated by accumulation of collagen compared to heart of wild-
type mice (Fig. 3.16. E, F). The fibrosis is more sever in septum and left ventricular wall than in 
right ventricular (Fig. 3.16D). These results reveal that Hspa4 disruption in the inbred 129/Sv 
genetic background causes cardiac hypertrophy and fibrosis. To determine the development of 
cardiac hypertrophy in Hspa4-/- mice, histological analysis of hearts and heart weight to body 
weight ratios (HW/BW) were performed in wild-type and Hspa4-mutant mice at different 
postnatal stages. In animals between 7- to 25-days of age, heart weight to body weight ratios 
(HW/BW) were not significant different from that of wild-type littermates (Fig.  3.17). In contrast, 
Hspa4-/- mice at 2- and 6- months of age showed a significant increase in HW/BW ratio compared 
to wild-type littermates (Fig. 3.17). Analysis of cross-sectional cardiomyocyte areas revealed no 
overt differences in morphology and size of myocytes between wild-type and mutant hearts 
isolated from mice at age between postnatal days 7 to 25 (Fig. 3.18A-F, 3.19O). Histological 
sections of hearts from these animals were stained with Massion's trichome staining to detect the 
extent of fibrosis. As shown in figure 3.16 G-L, the fibrosis is not yet realized in mutant hearts at 
these postnatal stages. Histological analysis of hearts from 2-3 and 6-month-old mice revealed that 
the size of left ventricular myocytes was markedly increased in Hspa4-/- mice compared with wild-
type mice (Fig. 3.19M, N, O). Vacuoles in cardiomyocytes and development of fibrosis were also 
prominent in hearts of 2-, 3- and 6-month-old Hspa4-/- mice (Fig. 3.19D-F, J-N). Increase of 
fibrosis areas was found in hearts of 2-, 3- and 6-month-old Hspa4-/- mice. These areas were 
















Fig. 3.16. Hspa4 deficiency causes cardiac hypertrophy and fibrosis. (A) External view of 
representative hearts from 12-month-old Hspa4+/+ (left) and Hspa4-/- (right) mice. (B and C) 
Histological sections of wild-type (B) and Hspa4-/- hearts (C) stained with H&E show 
degeneration and vacuoles in cardiomyocytes (white arrows). (D-F) Representative Massion's 
trichome–stained heart sections showing collagen-distribution (blue) in heart of Hspa4-/- mice , 
indicative for fibrosis (D). In sections of wild-type heart (E), no fibrosis was found. Right 





















Fig. 3.17. Heart weight to body weight (HW/BW) ratios in wild type and Hspa4-null mice. There 
was no significant difference in HW/BW ratio before 2 months of age between the Hspa4-null 
mice when compared with littermate controls.  HW/BW ratios of Hspa4-/- mice were significantly 
greater in 2-3-, 6-, 12-, 24 month-old compared with those of wild-type mice.  Data are mean ± 










































Fig. 3.18. Cardiac hypertrophy and fibrosis were not observed in 7 to 25 day- old Hspa4-mutant 
mice. Hematoxylin and eosin-stained cross sections of hearts obtained from wild-type (A, B, C)) 
and Hspa4-mutant (D, E, F) mice at postnatal day 7 (A, D), 16 (B, E), 25 (C, F) are shown. At P7 
(D), P16 (E) and P25 (F) heart sections did not show differences in morphology and size of 
cardiomyocytes between wild-type and mutant mice. (G-L) Representative  Massion’s trichome –
stained heart sections at postnatal day 7 (G, J), 16 (H, K), 25 (I, L)  without fibrosis in Hspa4-/- 
mice (J, K, L). Black lines indicate cardiomyocyte diameters in the region of the cell nucleus. 


































Fig.3.19. Cardiac hypertrophy and fibrosis were first observed in hearts of 2-month-old Hspa4-/- 
mice.  Hematoxylin and eosin- stained  cross sections of hearts obtained from wild type (+/+) (A, 
B, C) and Hspa4-mutant (-/-) (D, E, F) mice at month 2 (A, D), 3 (B, E ), 6 (C, F ) are shown. The 
2-, 3- and 6-month-old Hspa4-/- (D, E, F) hearts display severe signs of hypertrophy including 
increase of myocyte size, degeneration and loss of myocytes compared to control littermates. (G-
N) Representative Massion's trichome heart sections from  2- (G, J), 3- (H, K) and 6- (I, L, M, N) 
month-old Hspa4+/+ and Hspa4-/-  mice showing increased fibrotic areas (blue) in Hspa4-/-  heart 
(J, K, L, N).  Myocyte diameter of mutant and wild-type hearts (O). Black lines indicate 
cardiomyocyte diameters in the region of the cell nucleus, which were significantly increased in 
hearts of 6-month mutant mice. Collagen-containing fibrotic region is stained with blue color 
(white arrow). Optical magnifications: 4x in G-L; 60x in A-F, M, N, *, p <0.05; **, p <0.001. 
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3.2.6.2 Echocardiographyic measurements in wild type and mutant mice 
To further confirm the cardiac hypertrophy phenotype in Hspa4-mutant mice, 
echocardiogram was performed in 4-month-old wild-type (n=7) and Hspa4-null mice (n=10) 
(Fig. 3.20A, B). Two-dimensional directed M-mode echocardiograms were recorded to measure 
left ventricle end-diastolic and end-systolic dimensions, right ventricle and septal thickness. As 
shown in figure 3.20A-C, Hspa4-/- mice exhibit significant hypertrophy with increase of 
intraventricular septal thickness, left ventricle posterior wall thickness during diastole compared 
with age-matched wild-type control mice. The lumen of Hspa4-/- left ventricle was thinner than 
wild-type control (Fig. 3.20A, B). Left ventricular mass (LVM) as well as the left ventricular 
mass to body weight ratio (LVM/BW) were higher than in wild-type mice. However, the increase 
of LVM/BW ratio was not significant (Fig. 3. 20E, F). Furthermore, the calculated ratio of wall 
thickness to heart radius at diastole (H/R) was significantly increased compared to that in wild 
type mice, suggesting a concentric pattern of enlargement (Fig. 3.20G). At 17 days of age, the 
Hspa4- null mice showed a small degree of hypertrophy, but with a significant increase in septal 
wall thickness compared with wild- type controls (Fig.3. 20D). 
 
3.2.6.3 Ultrastructural analysis of sections Hspa4-/-  heart 
To further evaluate the morphological changes in cardiomyocytes of Hspa4-/- mice more 
precisely, we performed ultrastructural analysis on sections from left ventricular wall of 2-month-
old Hspa4+/+ and Hspa4-/- mice (Fig. 3.21A-F). Ultrastructural analysis revealed myofibrillar  
disarray and disassembly in Hspa4-/- heart . The structure of the myocyte nuclei was also 
markedly abnormal, with redundancy of vacuoles in the nuclei. Nuclei have bizarre shapes (Fig 
3.21E). Furthermore, increased collagen accumulation (fibrosis) was frequently observed in 
Hspa4-/- hearts (Fig 3.21C, F). In contrast, ultrastructure of wild-type heart did no show these 











































Fig. 3.20. Transthoracic echocardiography revealed affected dimensions and functions of 
Hspa4-/- hearts. (A and B) Shown two representive M mode images from heart of wild type (A) 
and null-mice (B). (C-G) Quantitative analysis of the diameter of diastolic left ventricular 
wall and septal of heart from 4-month- (C) and 17-day-old mice (D), left ventricular mass 
(LVM) (E) and LVM/BW ratio (F) of 4-month-old animals. (G) The H/R (left ventricular 
thickness/radius) ratio of 4-month-old heart shown marked increase of the H/R ratio in 
Hspa4-null mice. Data are mean ± SEM of 7 wild type and 10 Hspa4-/- mice; *, p <0.05; **, p 
<0.001, ventriclicular end-diastolic (right arrows) and end-systolic (left arrows). Ventricular 







3.2.6.4 Analyses of molecular markers of cardiac hypertrophy 
Ventricular hypertrophy induced by pressure or volume overload is known to lead to 
reactivation of several specific embryonic genes, such as atrial natriuretic factor (Anf), Brain 
natriuretic peptide (Bnf ), β-myosin heavy chain 7 (Myh7)and  skeletal α actins 1 (Acta1) 
(Komura  and Yaakov, 1993; Chine et al., 1991). In order to show at which postnatal stage the 
development of heart hypertrophy starts, we studied the expression of hypertrophic marker genes 
in the heart from different postnatal stages. Northern blots with RNA isolated from hearts at P10, 
P14, P15, P17, P19 , P37 and 3.5-month-old Hspa4+/+  and Hspa4-/- mice were hybridized  with 
32P-labeled Anf coda probe (Fig.3. 22). To check the integrity and equal amounts of RNA, the 
blots were rehybridized with  β-actins   coda probe . Northern blot analysis showed no difference 
in expression levels of Anf  in hearts of wild-type and null-mice at postnatal days 10 and 14. 
Expression level of Anf was increased in RNA of Hspa4-null hearts at postnatal day 15 (P15) 
compared with the control littermates. Thereafter, a significant increase in the level of Anf  
expression was observed through the postnatal developmental stages of Hspa4-null hearts. To 
further confirm these results, expression levels of  Anf, Bnf, Acta1 and β-Myh7 were determined 
at different postnatal stages by quantitative real-time RT- PCR (Fig. 3. 23A-D). The results 
revealed that the expression levels of hypertrophic marker genes are significantly higher  in 
Hspa4-/- hearts at postnatal days 15- 25 than in wild-type hearts. The expression levels of Anf , 
Bnf, Acta1 and β-Myh7 were increased 7.0-, 4.7-, 3.8- and 2.8- fold in Hspa4-/- mice, respectively 
, compared  with wild type.  These results suggest that reactivation of the fatal gene program in 
the Hspa4-null hearts.  Furthermore, the expression pattern of hypertrophy marker genes 
indicates that the development of hypertrophy in Hspa4-null mice starts in early postnatal life.  
 
3.2.6.5  Upregulation of fibrosis marker genes in heart of Hspa4-/- mice 
 The development of cardiac fibrosis in Hspa4-/- lead us to determine at molecular 
level the progression of fibrosis in heart of Hspa4-/- mice at different postnatal ages. We 
determined the expression levels of fibrosis marker genes collagen I, collagen III and transforming 
growth factor- β1(TGF- β1). Quantitative real-time PCR was used to characterize expression  






























A B C 
D E F 
Fig. 3.21. Ultrstructural analysis by transmission EM of Hspa4+/+ (A, D) and  Hspa4-/-  mice 
(B, C, E, F) reveals disarray and disassembly of myofibrils (white arrows) in Hspa4-/- (B) 
heart versus the normal architecture of wild-type heart (A, D). Nuclei of myofibrils from 
Hspa4-null mice exhibit irregular morphology with multiple inclusions (white arrow head) 
compared to the normal nuclear shape of control myocyte (D). Collagen accumulations are 













Fig. 3.22. Expression of the Anf gene in heart of wild-type and null mice at different postnatal 
stages.  Total RNA was extracted separated in 1% formaldehyde-agarose gel (15μg/lane), 
transferred onto nylon membrane and hybrdized with 32P-labelled Anf and β-actin cDNA 
probes, respectively. Northern blot showing an increase in Anf mRNA expression in heart of 






















































Fig.3.23. Expression of hypertrophy genes in hearts of wild-type and null-mice at different 
postnatal ages. The mRNA levels of Anf (A), Bnf (B), Myh7(C) and Acta1 (D) were quantified 
by real time RT-PCR (n=3 per group). The relative mRNA level of each gene was normalized to 
that of house keeping succinate  dehydrogenase (Sdha). Values indicate relative expression to  












As expected from the results of histological analysis for development of fibrosis in Hspa4-/- heart, 
no significance different in expression levels of collagen I, collagen III and TGF- β1 in heart of 
20-day-old wild-type and Hspa4-/- mice (Fig. 3.24 A-C), while significant increase in expression 
of collagen III and TGF- β1 were observed in heart of 50-day-old Hspa4-/- mice at compared to 
that of littermate control (Fig 3.24. B, C). Expression levels of all three genes were markedly 
increased in 3-month old Hspa4-/- heart compared to that of wild-type. These results reveal that the 
cardiac fibrosis is developed in Hspa4-/- heart at early postnatal age. 
 
3.2.6.6  Molecular pathways in the regulation of cardiac hypertrophy 
 Several molecular pathways have been implicated in the molecular response of 
cardiomyocytes to external stimuli or stress and in the development of cardiac hypertrophy. 
Gp130/STAT3, MAPK, Calcineurin-NFAT and P13K/Akt/GSK-3-depenent- signalings are 
among the best established mediators of cardiac hypertrophy. Alteration in the activity of one of 
these molecular signalings leads to development of cardiac hypertrophy (Frey and Oslon, 2003). 
To determine the signal pathway that is affected in Hspa4-/- mice and responsible for the 
development of cardiac hypertrophy, we determined the expression of some genes and proteins 
involved in Gp130/STAT3, MAPK and Calcineurin-NFAT signalings in heart of wild-type and 
Hspa4-/- mice.  
3.2.6.6.1  Analysis of STAT3 and MAPK signaling in heart of Hspa4-/- mice  
 Several studies have reported that IL-6-related cytokines such as LIF induced hypertrophy 
in cardiac myocytes through gp130 receptor. Activation of gp130 receptor leads to downstream 
activation of two signaling pathways, one is the JAK/STAT-, the other the MAPK pathway 
(Kishimoto et al., 1994; Kunisada et al., 1996). The transcription factor STAT3 is essential for 
gp130-mediated hypertrophy in heart. To study whether the STAT pathway is affected in Hspa4-
null heart, expression of STAT3 and phosphorylated STAT3 in heart of wild-type and mutant mice 
at different ages was determined by Western blot analysis. Total protein extracts were isolated 
from 3-week-, 3-, 6-, and 12-month-old wild-type and Hspa4-/- mice, separated on PAGE-SDS gel 
and blotted on nitrocellulose filters. Blots were probed with anti-STAT3, anti-phospho STAT3 and 
anti-α-tubulin antibodies. As shown in figure 3.25A, expression of STAT3 and activated STAT3 





























Fig. 3.24. Increase of fibrosis marker gene expression in Hspa4-mutant adult mice. Relative 
levels of collagen I (A) ,collagen III (B), and TGFβ1 (C) mRNA expression in heart of Hspa4-
null and wild type mice during cardiac postnatal development (15-20-, 50-and 90-day-old) 
are illustrated. Expression levels were normalized to the expression of endogenous control 






 MAPK signaling pathway consists of a sequence of successively acting kinases that result 
in dual phosphorylation and activation of terminal effector kinases such as ERK1/2 (Widmann et 
al., 1999). To determine whether the MAPK signaling is altered in heart of Hspa4-/- mice, 
expression of ERK1/2 and activated form (phospho-ERK1/2) was studied by Western analysis. 
Blots with heart protein extracts from wild-type and Hspa4-null mice at different ages were 
probed with ERK1/2, phospho-specific ERK1/2 and anti-α-tubulin antibodies. Western blot 
analysis revealed that the ERK1/2 and phospho-related ERK1/2 protein levels are similar in heart 
of wild-type and mutant mice at different ages (Fig. 3.25B). These results suggest that the both 



















Fig. 3.25. Expression of inactive and active STAT3 and Erk1/2 proteins in heart. Western 
blots with protein extracts from heart of 3-week, 3-, 6- and 9-month-old Hspa4+/+ and Hspa4-
/-  mice were probed with STAT3, phospho-specific STAT3 and α-tubulin antibodies (A). Blots 






3.2.6.6.2 Genes involved in calcineurin/NFAT pathway are upregulated in heart of Hspa4-/- 
mice 
Several studies have shown that the angiotensin-endothelin system induce the activity of 
calcineurin-NFAT signaling pathway (Abbasi, et al., 2006). Therefore, we determined the 
expression of genes coding for receptors that regulate the activity of downstream proteins in the 
calcineurin/NFAT pathway in heart of wild-type and Hspa4-null mice. These receptors include 
endothelin A (ETA) and B (ETB), angiotensin II type 1 (AT ) and type 21  (AT2) receptors. We 
measured the expression of these genes by real time PCR in heart at two postnatal ages. At P18, 
expression of most genes in heart of Hspa4-/- was slightly higher than that in wild-type littermates 
(Fig.3.26 A, B, D, E). Only expression of the gene coding for ET  endothelinB  receptor did not 
show any significant difference between heart of Hspa4-/-   and control mice at this postnatal age. 
In contrast, expression of the genes coding for these receptors was significantly up-regulated (at 
least 2-fold) in heart of 3-month-old Hspa4-/- compared to heart of control mice (Fig.3.26 A, B, 
D, E). The expression of angiotensin II gene that codes for the ligand of AT  and 1 AT2 receptors 
was also determined in the heart of both genotypes and ages. Similar to expression pattern of its 
receptor, expression of angiotensin II gene was slightly higher in heart of 18-day-old Hspa4-/- and 
4-fold higher in heart of 3-month-old Hspa4-/- mice than in heart of control littermates (Fig.3.26 
C). The expression of endothelin (ET-1) coding for ligand of ET and A ETB also showed the same 
pattern (Fig.3.26 F).  These results suggest that the Hspa4 deficiency alters the activity of 
angiotensin-endothelin pathway. To study whether the upregulation of these genes coding for 
ligands and receptors of angiotensin-endothelin pathway of 3-month-old Hspa4-/- mice is 
accompanied by increase of the activity of Calcineurin-NFAT signaling pathway, quantitative 
real-time PCR assays were performed to determine the mRNA levels of several genes that are 
involved in this signaling. The studied genes include natriuretic peptide receptor A (Npr1), 
calmodulin 1 (Calm), protein kinase C (PKC), myocyte-specific enhancer factor 2C (Mef2C), 
GATA4 binding protein 4 and histone deacetylase 7A (Hdac7a). As shown in figure 3.27, except 
for Calm, mRNA levels of all other genes were slightly higher in heart of 18-day-old Hspa4-/- 
mice than in control mice. In heart of 3-month-old mice, expression levels of all these genes were 
more than 2-fold higher in Hspa4-/- mice compared to control mice. These results suggest that the 


























Fig. 3. 26. Upregulation of genes that are involved in angiotensin- endothelin system in heart of 
Hspa4-mutants and controls. Quantitative real-time PCR analysis of mRNA levels for angiotensin 
II type 1 (AT ) (A) and type 21  (AT2) (B) receptors, angiotensin II (AngII) (C), endothelin A (ETA) 
(D) and B (ETB) (E) receptors and endothelin (ET-1)(F) wild type (WT) and mutant (KO) mice 
was determined  at 18-day- and 3-month-old . Expression levels were normalised to the 
expression of endogenous control (Sdha). 2-3 biological replicates were performed for each 
stage and genotype. 
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In calcineurin/NFAT signaling, calcineurin dephosphorylates and activates the NFAT 
transcription factors. The activated NFAT protein promotes together with other transcription 
factors such as Mef2C and GATA4 the expression of several hypertrophic induced genes. To 
determine whether calcineurin/NFAT pathway is highly activated in heart of   Hspa4-/- mice, we 
determined the expression of the NFAT-target gene, cardiac-specific transcript modulatory 
calcineurin interacting protein 1.4 (MCIP1.4). The promoter of MCIP1.4 gene contains specific-
acting element for NFAT proteins. Expression analysis revealed that the MCIP1.4 transcript level 
was 15-fold higher in heart of 3-month-old Hspa4-/- mice than in control mice. These results 
demonstrate that Calcineurin/NFAT signaling pathway is highly activated in heart of Hspa4-/- 
mice (Fig. 3.28). These results further suggest that elevated calcineurin/NFAT activity can 
modulate the cardiac hypertrophy of Hspa4-/- mice.  
 
3.2.6.7 Microarray analysis of cardiac gene expression 
 To investigate the pathways regulating the development of cardiac hypertrophy in 
Hspa4-deficient mice, microarray analysis was used as a screening tool to indicate genes with 
altered expression in the Hspa4-null hearts at 25 days compared with  that of wild type mice. We 
selected 25-day-old Hspa4-/- and control mice because at that age expression of marker genes for 
cardiac hypertrophy and fibrosis is slightly increased in heart of Hspa4-/- mice (sections 3.2.6.4 
and 3.2.6.5). RNA from these wild-type and Hspa4-/- mice, respectively, was prepared and 
labeled coda was hybridized to GeneChip® Mouse Gene 1.0 ST Arrays. The specificity of results 
obtained by microarray analysis was firstly confirmed by studying downregulation of Hspa4 gene 
(4-fold decrease) and upregulation of hypertrophic markers such as Anf, Bnf, Myh7 and Acta1, 
which were found to be upregulated in Hspa4-/- heart by real time PCR described in section 
3.2.6.4. There were 98 genes with statistically significant altered expression of at least +/-1.5 fold 
with P values of < 0.05, of which 42 were upregulated and 56 downregulated in Hspa4-/- heart 
compared to corresponding wild-type (Table 3.1). Several genes were selected and classified 



























Fig.3.27. Expression levels of Npr1 (A) calmodulin 1 (B), PKC (C), Mef2C (D), GATA4 (E) 





 and control mice at 18 days and 3 months of age. 
Expression levels were normalized to the expression of endogenous control (Sdha). 2-3 




















Fig.3.28. Overexpression of MCIP1.4 in heart of Hspa4-deficient mice. Values represent 
relative levels of MCIP1.4 in heart of 25-day- and 3 month- old animals. mRNA expression 
levels in each sample were normalized to the expression of Sdha. 2-3 biological replicates 
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Symbol Description Function log2FC KOvsWT 
Myh7 myosin, heavy 
polypeptide 7, cardiac 
muscle, beta 
calmodulin binding , 
striated muscle thick 
filament , striated muscle 








homeobox 4 (Drosophila) 
 
Regulation of transcription, 
heart development, 











Nrbp2 nuclear receptor binding 
protein 2 
protein kinase activity, ATP 




Rnf207 ring finger protein 207 protein binding, intracellula 








Zyx zyxin protein binding, cell-cell 





Eif4ebp1 eukaryotic translation 
initiation factor 4E 
binding protein 1 
translation initiation factor 
activity regulation of 




Hspg2 perlecan (heparan sulfate 
proteoglycan 2) 




Gata6 GATA binding protein 6 transcription regulator 
activity, metal ion binding 
0.52 
 
Rmrp RNA component of 
mitochondrial RNAase P 
Molecular function 0.51 
 
Nppb (Bnf) natriuretic peptide 
precursor type B 
 




Stk17b serine/threonine kinase 
17b (apoptosis-inducing) 
protein amino acid 
phosphorylation 








Mrc1 mannose receptor, C type 
1 
receptor activity, calcium ion 
binding 
, integral to membrane 
-0.50 
 
Mpdz multiple PDZ domain 
protein 
 protein binding, tight 
junction 




Kras v-Ki-ras2 Kirsten rat 
sarcoma viral oncogene 
homolog 
nucleotide binding, GTPase 
activity 
, GTPase activity, protein 











Mrgprh MAS-related GPR, 
member H 



























































protein amino acid 
glycosylation 
integral to membrane , 
manganese ion binding 
-0.52 
 
Pkia protein kinase inhibitor, 
alpha 
 negative regulation of 
transcription 
from RNA polymerase II 
promoter 





Tm4sf5 transmembrane 4 
superfamily member 5 
integral to membrane -0.52 
 
Lrtm1 leucine-rich repeats and 
transmembrane domains 
1 
protein binding, membrane, 
integral to membrane 
-0.53 
 
Kcnd2 potassium voltage-gated 
channel, Shal-related 
family, member 2 




3110057O12Rik RIKEN cDNA 
3110057O12 gene 
extracellular region -0.54 
 
C7 complement component 
7 
complement component 7 -0.55 
 







hydroxylase), alpha 1 
polypeptide 
 










Dcun1d1 DCN1, defective in cullin 
neddylation 1, domain 




Dab2 disabled homolog 2 
(Drosophila) 
involved in differentiation 
cell 
morphogenesis  and 





Alkbh8 alkB, alkylation repair 










Zmpste24 zinc metallopeptidase, 
STE24 homolog (S. 
cerevisiae) 
metalloendopeptidase 
activity, proteolysis,  
nuclear envelope 








gated, type IV, alpha 
 




Myl1 myosin, light polypeptide 
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Symbol Description Function log2FC KOvsWT 




Ptp4a1 protein tyrosine 
phosphatase 4a1 





AW061290 expressed sequence 
AW061290 














Tbc1d8b TBC1 domain family, 
member 8B 
GTPase activator activity & 





Fktn fukutin  






nucleotide-gated K+ 1 
 
potassium channel activity, 














































C3 complement component 
3 
positive regulation of type 
IIa, 





Lgi1 leucine-rich repeat LGI 
family, member 1 
protein binding , extracellular 
region 
-1.09 
Maob monoamine oxidase B mitochondrion,amine oxidase 
activity 










Hspa4 heat shock protein 4  -2.01 
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A- Hypertrophic markers 
 
Anf natriuretic peptide 













myosin, heavy polypeptide 













B- Hypertrophy related genes 
 
Fktn fukutin - 0.71 
 







GATA binding protein 6 0.52 
 
-GATA factors are 
sufficient regulators of 
cardiomyocyte 
hypertrophy 
- Overexpression in 
transgenic mice induce 
hypertrophy 
 
Igfbp3 insulin-like growth factor 
binding protein 3 
o.64 Mice overexpressed of 
hIgfbp3-   has 
organomegaly 
 






subfamily, member 1 
 
1.02 - Involved in potasium 
channel 
-  Overexpression of 
KCNE1 in transgenic 
mice resulted in a 
cardiac phenotype 




mice, including a lower 
heart rate and 













family, member 2  
-The down-regulation 
of kcnd2 expression 





Scn4a sodium channel, voltage-
gated, type IV, alpha 







nucleotide-gated K+ 1 
-0.7 -It contribute to 
spontaneous rhythmic 
activity in both heart 
and brain 
Irx4 Iroquois related homeobox 
4 (Drosophila) 












monoamine oxidase B -1.11 
 
-Neutralized oxygen in 
mitochondria, 





guanine nucleotide binding 
protein, alpha O 
0.75 
 
-Is critical target of 
oxidative stress 
 
Ptp4a1 protein tyrosine 
phosphatase 4a1 
-0.65 -It stimulates cell 
growth (stimulates 
progression from G1 
into S phase during 
mitosis) 
-It is  modulated under 
oxidative stress 
Mme (NEP) membrane metallo 
endopeptidase 




E- synaptic junction 
 
Lgi1 leucine-rich repeat LGI 
family, member 1 







The differentially expressed  genes include natriuretic peptide precursor type A (Anf), natriuretic 
peptide precursor type B (Bnf), actin, alpha 1, skeletal muscle (Acta1) and myosin, heavy 
polypeptide 7, cardiac muscle, beta (Myh7) and genes involved in ion channel signaling, 
potassium voltage-gated channel, Isk-related subfamily, member 1( Kcne1), potassium voltage-
gated channel, Shal-related family, member 2 ( Kcnd2), sodium channel, voltage-gated, type IV, 
alpha (Scn4a), hyperpolarization-activated, cyclic nucleotide-gated K+ 1 (Hcn1) and Iroquois 
related homeobox 4  (Irx4). In addition, differential expression of genes, which are involved in 
protection of cells against oxidative stress, were also observed. These genes are guanine 
nucleotide binding protein, alpha O (Gnao1), protein tyrosine phosphatase 4a1 (Ptp4a1) and 
membrane metallo endopeptidase (Mme). We have also studied the expression of the monoamine 
oxidase B (Maob), which induces the oxidative stress in cardiomyocyte by oxidation of 
monoamine to hydrogen peroxide in the mitochondria (Naoi et al., 2006). The Maob is 
downregulated in Hspa4-/- heart by microarray analysis.  
 
3.2.6.8    Quantitative real-time PCR analysis 
Quantitative real-time PCR analysis was used to confirm the expression levels of selected 
genes shown to be differentially expressed by microarray analysis. cDNAs of heart were prepared 
from 25- day- and 3-month-old mice and used to determine the expression  of  Kcne1, Kcnd2, 
Scn4a, Hcn1, Irx4,  Maob, Mme, Gnao1, Ptp4a1, GATA6, Fktn, Igfbp3, Lgi1 by quantitative real 
time PCR. In 18-day- and 3-month-old Hsp4a-null heart, expression of  Kcne1 and Irx4 
transcripts that control K+  channel was upregulated in Hspa4-null ventricle compared with 
control (Fig.3. 29A, B ). Whereas the expression of Kcnd2, anther gene encoding for Potassium 
voltage-gated channel subfamily D member 2, was significantly downregulated in mutant heart 
(Fig.3.29C). The expression of Hcn1, encoding pacemaker channel protein, was significantly 
reduced in Hspa4-mice in comparison to wild-type (Fig.3.29D). Expression of Scna4 was also 
















































Fig. 3.29.  Expression levels of Kcne1 (A), Irx4 (B), Kcnd2 (C), Hcn1 (D) and Scn4a (E)  in 
hearts of wild-type and  Hspa4-/- mice at age of 25 days and 3 months. Quantitative real time 
PCRs were carried out in triplicate and in 3 mice per group at different postnatal stages. All 




Maob is involved in the metabolism of serotonin and catecholamines that generates 
hydrogen peroxide (H O ). Defects in this pathway lead to an increase of 2 2 serotonin and 
catecholamines, which leads to an increase of blood pressure, and in consequence to 
cardiomyopathy. In 25-day- and 3-month-old Hsp4a-null heart, the expression level of Maob was 
significantly reduced compared with wild-type at both ages (Fig.3.30A). The downregulation of 
maob may be one of the causes for development of hypertrophy in Hspa4-deficieny. Expression 
of Gnao1 is known to be induced by reactive oxygen species (Nishida, et al., 2000). Levels of 
Gnao1 mRNA were significantly increased in heart of 25-day- and 3-month-old mice mutant 
compared with wild-type (Fig.3.30B). The Mme is a proteolytic enzyme responsible for 
degradation of Anf. Quantitative real time PCR showed that gene expression of Mme is 
significantly reduced in Hspa4-/- heart compared with wild type (Fig. 3.30C). The zinc finger-
containing transcription factors GATA4 and GATA6 are important regulators of basal and 
inducible gene expression in cardiac and smooth muscle cell types. Overexpression of either 
GATA4 or GATA6 is sufficient to induce cardiomyocyte hypertrophy characterized by enhanced 
sarcomeric organization (Liang, et al, 2001). In Hspa4-/- heart, GATA6 was significantly 
increased in comparison with wild-type (Fig. 3.30D). Treatment of cardiac myocyte cultures with 
Igfbp-3 demonstrated an increase in Anf expression level (Henson et at., 2000). A significant 
increase of Igfbp-3 transcript was observed in heart of Hspa4-/- mice at 25 days and 3-months of 
age compared with wild type (Fig. 3.30E). Mutation of Fktn cause hypertrophic cardiomyopathy 
and muscular dystrophy (Arimura, et al., 2009). Analysis of the expression of Fktn showed that 
expression of this gene is relatively low in 25-day-old wild-type and mutant heart, but its 
expression level at 3-month-old heart did not significantly differed between WT and KO mice 
(Fig. 3.30F). Leucine-rich, glioma inactivated 1 (Lgi1) regulates voltage-gated potassium 
channels assembly of Kcna1, Kcna4 and Kcnab1 and positively regulates synaptic transmission 
mediated by AMPA-type glutamate receptors. At day 18 and at 3-months, expression levels of 





























Fig. 3.30 Relative levels of Maob (A), Gnao1 (B) Mme (C) GATA6 (D), Igfbp3 (E) Fktn (F) 
and Lgi1 (G) mRNA expression in heart of Hspa4-/- mice at age of 25 days and 3 months. 
Expression levels were normalised to the expression of endogenous control (Sdha). The 










3.2.7    Expression analysis of HSPA4L and HSPH1 in Hspa4-deficiency 
 Two other members of   HSP110 family (HSPA4L and HSPH1) have been reported to be 
localized in cytoplasm as HSPA4. We examined the expression of both genes in Hspa4-/- heart at 
protein level, because Hspa4-deficiency may alter the expression levels of both proteins.  Total 
protein extracts were isolated from heart of 3-month-old wild-type and Hspa4-/- mice, separated on 
PAGE-SDS gel and blotted on nitrocellulose filters. Blots were probed with HSPA4, HSPA4L and 
HSPH1 antibodies. No change in expression levels of HSPA4L and HSPH1 proteins were 
detected in the heart of Hspa4-deficient mice (Fig. 3.31). These results suggest that the loss of 
Hspa4 expression in Hspa4-/- heart is not compensated for by a detectable increase of the 



























Fig. 3.31.   Expression of HSPA4L and HSPH1 in heart of Hspa4-/- mice. Western blots with 
protein extracts from heart of 3--month-old Hspa4+/+ and Hspa4-/- mice were probed with anti-
HSP4A , HSPA4L  and HSPH1 antibodies. The membranes were stripped and subsequently 








3.2.8 The effect of aging and oxidative stress on expression of HSPA4  
At least 11 families of HSPs have been described. Most of them are expressed 
constitutively or strongly induced by stress conditions such as heat, osmotic or oxidative stress. 
Expression of other HSPs is induced at certain developmental stages (Bodega et al., 2002). It is 
also known that biochemical stresses resulting from hypertension, hypoxia and other forms of 
myocytes injury induce cardiac hypertrophy. Biochemical stresses affect the folding of proteins 
and cause a progressive loss of cardiomyocytes. Therefore, increased expression of HSP proteins 
prevents accumulation of misfolded proteins in cells. We have determined whether the expression 
of HSPA4 is increased in response to different stresses. Firstly, we determined the HSPA4 
expression in wild-type heart at different ages. It is known that old hearts are exposed to more 
stresses than young hearts. Total cellular proteins were isolated from 3-, 6-, 9-, 12-month-old 
wild-type heart, electrophoresed on SDS-PAGE and transferred onto a nitrocellulose membrane. 
The Western blot was probed with HSPA4 antibody. Thereafter, the membrane was stripped and 
subsequently probed with HSP4L antibody. As shown in figure 3.32, the expression of HSPA4 is 
significantly increased in hearts with advancing age. In contrast, the expression level of HSP4L 
was not changed with increasing age.  
These results lead us to suggest that the upregulation of Hspa4 in aging heart is linked 
with accumulation of stress such as oxidative stress. To prove the validity of this hypothesis, the 
expression of Hspa4 in heart was studied after paraquat injection, which induces oxidative stress. 
3-month-old- wild type mice (n=3) were intraperitoneally injected with paraquat (50 mg/kg body 
weight). Control mice (n=3) were injected with PBS. Heart tissues were isolated from the mice 7 
hrs after injection. Firstly, we checked whether the paraquat treatment induces oxidative stress in 
heart by analysis of the expression of oxidative stress marker superoxide dismutase [Cu-Zn] 
(SOD1) and Gnao1 (G protein binding) by quantitative real time PCR. The results demonstrate 
that the expression levels of SOD1 and Gnao1 are increased in heart of paraquat- injected mice 
compared to untreated mice (Fig. 3.33A, B). This result suggests that paraquat induces the 
oxidative stress in heart. However, there were no significant differences in the expression levels 
of Hspa4 between heart of paraquat-treated and control mice (Fig. 3.33C). These results suggest 
















Fig. 3.32.  Increased expression of HSPA4 with aging. Western blot of HSPA4 expression in 3-, 




































Fig.3.33. Effect of oxidative stress on expression of Hspa4 in heart. Expression of heart  SOD1 
(A) ,Gnao1 (B), Hspa4(C),  genes in 3-month-old wild-type mice after paraquat (PQ) injection 
measured by real-time PCR . Expression of these genes normalized by Sdha and compared with 















4. Discussion       
 
   4.1 Overview of results of this study 
 Analysis of Hspa4 mutant mice in hybrid C57BL/6J x 129/Sv genetic background 
demonstrated that male infertility is the most apparent phenotype. Number of spermatozoa and 
their motility in epididymis of infertile Hspa4-null mice were found to be drastically reduced, 
suggesting that spermatogenesis is disrupted (Held, 2008). To identify the spermatogenic stage at 
which spermatogenesis is affected by Hspa4 deficiency, testicular sections from different 
postnatal days were histologically and immunohistologically analysed. The results of these 
studies revealed that Hspa4-deficiency resulted in partial arrest of the first wave of 
spermatogenesis at the late stage of prophase I. To determine whether the observed loss of germ 
cells is a result of enhanced apoptosis in Hspa4-null mice, Tunnel assay was performed. The 
results of these analyses indicated that germ cells at meiotic stages appear to be the most affected 
cells in Hspa4-deficient testis. Furthermore, the down-regulation of transcription levels of genes 
known to be expressed in spermatocytes at late stages of prophase I and post-meiotic spermatids 
let us suggest to that spermatogenesis is arrested at late stages of meiotic prophase I. These results 
provide evidence that HSPA4 is required for normal spermatogenesis. 
In contrast to Hspa4 deficiency in the hybrid C57BL/6JX129/Sv genetic background, 
most of Hspa4-deficient mice with the inbred 129/Sv genetic background display growth 
retardation and die between the third and fourth week after birth. To identify whether the 
cause of growth retardation is due to defect in glucose homeostasis, we determined the serum 
glucose levels during postnatal development. The results showed that a reduction of blood 
glucose level is only manifested in Hspa4-/- animals at age between 22 to 28 days.  However, 
hypoglycemia found in fasted Hspa4-/- mice is not due to impaired gluconeogenesis. To 
address the question whether their growth retardation is a result of malabsorbtion of lipids in 
the intestine, expression analyses of apolipoprotein components of chylomicrons (ApoB and 
ApoAIV) were performed by RNA analysis. The ApoB gene is upregulated in intestine and 
liver of Hspa4-/- mice at postnatal days 20 and 25, while the level of ApoAIV mRNA is 
higher in intestine of 20- and 25-day-old Hspa4-/- mice. The upregulation of both 
apolipoprotein genes let us to suggest that the proteins in Hspa4-/- intestine are unstable. The 
degradation of both proteins may lead to feedback regulation and upregulation of ApoB and 
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ApoIV genes. However, Western blot analysis did not show a significant reduction of APOB 
proteins in Hspa4-/- intestine (Held, 2008). These results suggest that the absorption of lipid in 
Hspa4-/- intestine is not affected. We have then determined whether the growth retardation can 
be due to a defect in growth hormone (GH) signaling. However, normal expression of two 
GH-responsive genes in liver of Hspa4-/- mice excludes the impairment of the GH-signaling 
in Hspa4-deficient mice.   
Development of kyphosis in Hspa4–deficient mice of advanced age leads us to 
examine whether these mice suffer from skeletal muscle myopathy.  Microscopic examination 
of different skeletal muscles was carried out on 4-month-old wild-type and Hspa4-/- mice.  
Tibialis anterior, Vastus intermedius and Soleus muscles of Hspa4-/- mice were found to 
display myopathic changes.  An abundant pathology was found in paraspinal muscle of 18-
month-old mice. These results suggest that myopathy of the paraspinal muscle is a cause of 
kyphose development in aging Hspa4-/- mice. Furthermore, skeletal muscle myopathy was 
also shown in 13- and 19-day-old Soleus muscle of Hspa4 -/- mice. This indicates that growth 
retardation in Hspa4-/- mice is a result of skeletal muscle myopathy. 
To determine whether skeletal muscle myopathy is also realized in heart as 
hypertrophic cardiomyopathy, hearts from 12-month-old wild-type and Hspa4-deficient mice 
in the inbred 129/Sv genetic background were subjected to histological analysis. These 
histological analyses revealed the development of hypertrophic cardiomyopathy and fibrosis 
in Hspa4-/- mice. Further histological analyses revealed that cardiac hypertrophy and fibrosis 
were first observed in hearts of 2-month-old Hspa4-/- mice. Two-dimensional directed M-
mode echocardiograms were performed to further confirm the cardiac hypertrophy phenotype. 
Significant hypertrophy with increase of interventricular septal thickness, left ventricle 
posterior wall thickness during diastole compared with control littermates was found. 
Furthermore, the calculated ratio of wall thickness to heart radius at diastole (H/R) was 
significantly increased in mutant mice, suggesting a concentric pattern of enlargement. 
Echocardiographic measurement in Hspa4-null mice at 17-days of age showed a lower degree 
of hypertrophy but with a significant increase in septal wall thickness compared with wild-
type controls. Ultrastructure analysis revealed myofibrillar disarray and disassembly, 
abnormal nuclei and increased collagen accumulation (fibrosis) in heart of Hspa4-/- mice. To 
identify when the development of cardiac hypertrophy and fibrosis starts in Hspa4-/- heart, we 
studied expression of marker genes for hypertrophy and fibrosis in hearts from different 
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postnatal stages by Northern blot and real time PCR analyses. These results indicated that the 
development of cardiac hypertrophy and fibrosis in Hspa4-null mice starts in early postnatal 
life. We suggest that the early postnatal lethality in Hspa4-/- mice in inbred 129/Sv genetic 
background could be due to the progression of skeletal and cardiac muscle myopathy. 
In order to identify the signal pathways that mediate cardiac hypertrophy in Hspa4-/- mice, 
we determined the expression of some genes and proteins, which are involved in Gp130/STAT3, 
MAPK and calcineurin-NFAT signaling pathways, in heart of wild-type and Hspa4-/- mice. The 
results of these analyses suggest that STAT3 and MAPK signaling pathways are not responsible 
for the development of cardiac hypertrophy in Hspa4-null mice. However, the increased activity of 
calcineurin/NFAT in Hspa4-/- heart can be responsible for modulation of the cardiac hypertrophy.  
Microarray analysis was used as a screening tool to identify altered expression in the 
Hspa4-deficient hearts at 25 days compared with that of wild-type mice. 98 genes were identified 
as differentially expressed. Several genes were selected and classified according to their function 
in the development of cardiac hypertrophy (Table 3.2). To confirm the results of microarray 
analysis, quantitative real-time PCR was performed. We confirmed that genes involved in ion 
channel signaling (Kcne1, Kcnd2, Scn4a, Hcn1 and Irx4), in protection of cells against oxidative 
stress (Gnao1, Ptp4a1 and Mme1) and in inducing oxidative stress (Maob) are differentially 
expressed in heart of Hspa4  mice as compared to wild-type mice.  -/-
 
Expression analysis of HSPA4L and HSPH1 proteins in Hspa4 heart was done in order 
to show whether the expression of these 
-/- 
members of HSP110 family are altered in Hspa4 
deficiency. The loss of expression of Hspa4 in Hspa4 heart is not compensated for by a 
detectable increase in the expression of 
-/- 
Hspa4l and Hsph1. It is known that older hearts are 
exposed to more stress than young hearts. To investigate whether the expression of HSPA4 
protein increases with aging, we determined the HSPA4 expression in wild-type heart at different 
ages. The data showed that the expression level of HSPA4 is significantly increased in hearts 
with advanced age. This result leads us to examine the expression of Hspa4 under condition of 
oxidative stress. Results of this experiment suggest that expression level of Hspa4 is not induced 






4.2 The role of HSPA4 for germ cell development 
Expression of HSPA4 is widespread in different tissues (Yasuda et al., 1995; Kaneko et 
al, 1997; Xue et al., 1998). However, the HSPA4 expression is highly enriched in male and 
female germ cells of prenatal gonads. Expression of HSPA4 in male gonocytes is gradually 
decreased after their migration to basement layers of seminiferous tubules and differentiation to 
spermatogonia (Held, 2008). The preferential expression leads us to study the specific role of 
HSPA4 in germ cell development. Analyses of Hspa4-deficient mice revealed that all Hspa4-null 
mice of the hybrid 129Sv X C57Bl/6J background were born at Mendelian ratio and were 
apparently normal, although expression of HSPA4 can be detected in all tissues of wild-type 
mice. Male infertility was the most apparent phenotype for Hspa4-deficient mice. Male infertility 
is histologically characterised by a decreased number of postmeiotic germ cells, and an increased 
number of meiotic and postmeiotic cells undergoing apoptosis. Hspa4 mutants display an arrest 
of the first wave of spermatogenesis in juvenile testes by postnatal day 15 when the most 
advanced germ cells in the testes remain at the late pachytene spermatocyte stage. These results 
indicate that Hspa4 deficiency impair the development of most germ cells in late prophase I.  
Numerous proteins that are required for the development of male germ cells through 
meiotic and post-meiotic stages are mostly translated in pachytene spermatocytes (Mons et al., 
1999). Failure of molecular chaperones to direct correct folding of newly synthesized proteins in 
pachytene spermatocytes might lead to accumulation of misfolded and damaged proteins, which 
would trigger spermatocytes to release meiotic division and initiate apoptosis. Based on the high 
similarity of HSP110 family members, we expected that the molecular chaperones, which also 
include the NEF members of HSP110 family, would be abnormal or partially affected in Hspa4-/- 
mice.  
The relatively leaky phenotype of Hspa4-deficient mice led us to suggest that other 
members of HSP110 family can partially compensate for the loss of HSPA4 function. HSPA4l 
and HSPH1 were possible candidates, since both proteins are widely expressed and localized in 
the cytoplasm like HSPA4. Therefore, compensation for the absence of HSPA4 by HSPA4L and 
HSPH1 would be the cause that Hspa4-/- mice are viable and display normal development except 
for disruption of spermatogenesis. We tested this possibility by Western blot analysis. However, 
we did not detect a significant up-regulation of HSP4AL or HSPH1 expression in Hspa4-/-   testes. 
Impaired male fertility was also reported for Hspa4l-deficient mice (Held et al., 2006). 
Thus, approximately 42% of Hspa4l–/– male mice suffered from fertility defects. Whereas the 
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seminiferous tubules of Hspa4l–/– testes contained all stages of germ cells, the number of mature 
sperm in the epididymis and sperm motility was drastically reduced. The reduction of the sperm 
count was due to the elimination of a significant number of developing germ cells via apoptosis. 
Partial penetrance and similarity of male infertility phenotype in both Hspa4 and Hspa4l 
knockout mice prompted us to generate HSPA4 and HSPA4L double knockout mice. Analyses of 
double knockout mice revealed that the Hspa4-/-/Hspa4l-/- mice are dying immediately after birth 
(Held, 2008). Immunohistological analysis demonstrated that the number of gonocytes in Hspa4-/-
/Hspa4l-/- testes of E18.5 was not significantly reduced compared to wild-type littermates (data 
not shown). 
The expression of some HSP proteins is inducible by environmental stress, but expression 
of others can be either constitutive or developmentally regulated (Dix, 1997). The HSPA4L is 
highly expressed in spermatogenic cells, from late pachytene spermatocytes to postmeiotic 
spermatids. No HSPA4L could be detected in germ cells of prenatal testis and ovary (Held et al., 
2006; unpublished results). In contrast, HSPA4 and HSPH1 are ubiquitously expressed proteins 
and become relatively enriched in gonocytes after colonization of gonads by primordial germ 
cells (Held, 2008). The enrichment of both proteins in germ stem cells suggests their significant 
role for male and female germ cells. The results showed that gonocytes are not affected in Hspa4-
deficient mice suggesting a redundant function of both proteins in germ cell development. To our 
knowledge, there is no report describing abnormal spermatogenesis in Hsph1-deficient mice. In 
one study, Hsph1-null mice were described as normally fertile (Nakamura et al., 2008). The 
generation of HSPA4 and HSPH1 double knockout mice will help us to study the role of both 
proteins in development of germ stem cells in male and female gonads. 
Several reports which used microarray analysis to identify preferentially expressed genes 
in different stem cells revealed that the Hspa4 is highly expressed in embryonic and different 
tissue-specific stem cells and its expression is down-regulated in their differentiated counterparts 
(Ramalho-Santos et al., 2002; Bhattacharya et al., 2004). Hspa4 was one of 216 enriched genes, 
which were found to be expressed at high levels in embryonic, neural and hematopoietic stem 
cells. Our results demonstrating high expression of HSPA4 in gonocytes further confirm the 
requirement of HSPA4 function for development of germ stem cells. Although the physiological 
role of molecular chaperones for self-renewal of stem cells is not known, it is believed that 
molecular chaperones may protect stem cells from aging due to oxidative stress (Ramalho-Santos 
et al., 2002). Caenorhabditis elegans that have an extended life-span have elevated levels of 
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molecular chaperones and enzymes that process oxidative free radicals and appear to be resistant 
to environmental stress (Finkel and Holbrook, 2000).  
A high incidence of male infertility was found among Hspa4-null mice in F2 generation, 
which contains a high level of inter-individual genetic variability. The decline in incidence of 
infertility phenotype in subsequent generations would point to a selection bias against that 
genotype. Therefore, partial penetrance of male infertility among Hspa4-null mice may be due to 
segregation of genetic modifier on the mixed genetic background. Analyses of different mice 
models revealed the consequence of background-related differences in male infertility 
phenotypes. Mice deficient for Tnp2, mitochondria solute carrier protein (MSCP), POU domain 
class 5  transcription factor 2 (Sperm-1), Hspa4l and insulin-like 6 (Insl6) showed the highest 
incidence of male infertility in F2 generation and in inbred genetic background (Bitgood et al., 
1996; Pearse et al., 1997; Yu et al., 2000; Adham et al., 2001; Nayernia et al., 2002; Burnicka-
Turek et al., 2009). 
 Several reports demonstrated the essential role of other heat shock proteins in the progress of 
spermatogenesis. Male Hsp70-2 knockout mice are infertile, whereas females are fertile. Like 
spermatogenic arrest in Hspa4-deficient mice, spermatogenesis of Hsp70-2-/- is arrested in 
prophase I of meiotic division. The number of apoptotic spermatocytes was slightly increased in 
Hsp70-2-mutant mice on postnatal day 15 and increased significantly at P17 (Dix et al., 1997; 
Mori et al., 1997). According to phenotype similarity between Hspa4- and Hsp70-2-deficient 
mice, we suggest that HSPA4 might be a cochaperone of HSP70-2 and the chaperone containing 
HSP70-2 and HSPA4 has an essential role in repair and clearance of misfolded proteins during 
meiotic phase of spermatogenesis. To prove this hypothesis, we have to check in the future 
whether HSPA4 interacts with HSP70-2. 
BAT3 is a member of the Bag family that acts as a cochaperone for the heat shock protein 
HSP70 and is involved in various developmental processes, cellular stress and viability (Corduan 
et al., 2009). Most Bat3-deficient male germ cells die at meiotic prophase I and Bat3-/- testes 
contain increased number of apoptotic germ cells. Interestingly, the testis specific Hsp70-2 
protein was undetectable in Bat3-deficient germ cells even though Hsp70-2 transcript levels were 
normal. Further experiments revealed that Bat3 interacts with Hsp70-2 and this interaction 
protects Hsp70-2 from degradation (Sasaki et al., 2008). In yeast, HSP110 proteins are a 
nucleotide exchange factor for HSP70 proteins. On the basis of the similarity in phenotype 
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between knockout mice for Hspa4, Hsp70-2 and Bat3, we suggest that HSPA4, BAT3 and 
HSP70-2 cooperate to regulate diverse chaperone-assisted processes in male germ cells at 
pachytene stage. Adepletion of one of these proteins could be a cause for accumulation of 
damaged proteins and a signal to induce cell death.  
In a current study immunostaining with an antibody against synaptonemal complex 
protein 3 (SYCP3) showed that the formation of synaptonemal complexes in the Hspa4-/- meiotic 
cells was indistinguishable from that in wild-type. In contrast, a higher number of unsynapsed or 
partially synapsed chromosomes was observed in pachytene spermatocytes of Bat3-deficient 
testis. Immunostaining with anti-phosphorylated histone H2AX antibody, which recognizes DNA 
double strand breaks, revealed  that multiple γ-H2AX–positive foci were observed on paired and 
unpaired Bat3−/− chromosomes (Sasaki et al., 2008). These data indicate that multiple synaptic 
abnormalities occur in Bat3- deficient pachytene spermatocytes. HSP70-2 has been found to 
associate with the lateral element of the synaptonemal complex (SC) (Allen et al., 1996). 
Although SC assembled in early pachytene stage of Hsp70-2-/- mice, later studies showed that SC 
was fragmented at late pachytene stage. Immunostaining of wild-type pachytene spermatocytes 
with anti-HSPA4 antibody revealed that HSPA4 protein is not associated with SC. These data 
suggest that HSPA4 is not involved in the regulation of chromosome dynamics during meiosis. 
The expression of heat shock Hsc70t gene is restricted to post-meiotic spermatids (Zakeri 
and Wolgemuth, 1987; Maekawa et al., 1989; Matsumoto and Fujimoto, 1990). Hsc70t-/- male 
mice have normal fertility and histological studies indicated that germ cell development during 
the late postmeiotic phase was not affected. However, ATP levels are low in the sperm of Hsc70t-
deficient testis and their ability to produce ATP appears to be compromised. This suggests that 
HSC70t possesses unique chaperone capabilities that are required by postmeiotic germ cells for 
the assembly and function of protein complexes involved in energy production (Eddy, 2002). 
 
4.3 Potential role of Hspa4 in regulation of cell cycle 
Arrest of spermatogenesis during meiosis lead us to suggest that Hspa4 has a role in 
control of cell cycle during meiotic division. Among the most well established heat shock effects 
on cell cycle kinetics are the transient arrests of cells at the G1/S or G2/M border (Kühl and 
Rensing, 2000). During cell cycle, chaperones play an important stabilizing role. They associate 
with cell cycle or signal proteins in order to translocate them to their targets, to keep them in a 
required conformational state, or to eliminate degraded or mutated forms (Sato and Torigoe, 
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1998). It has been reported that HSPA4 regulates cell cycle by competing the transcription factor 
ZONAB for binding to the SH3 domain of ZO-1. As a result of a dissociation of ZONAB/ZO-1, 















Fig. 4.1. Potential function of HSPA4 as a regulator of cell cycle. HSPA4 compete with ZONAB 
for binding to the SH3 domain of ZO-1. At low level of HSPA4 or during binding of HSPA4 with 
HSP70 chaperone, ZO-1 binds to ZONAB. This interaction accumulates ZONAB in cytoplasm 
and arrest the cell cycle at G1 phase. At high level of HSPA4 or when the process of folding and 
correct the misfolded protein successfully completed during the G1 phase, HSPA4 releases the 
HSP70 chaperone and then binds to ZO-1 resulting in dissociation of ZONAB from ZO-1. 
Subsequently, ZONAB interacts then with CDK4 and ZONAB-CDK4 translocates from cytoplasm 
to nucleus. In nucleus, ZONAB-CDK4 regulates G1/S phase transition by transcriptional 
regulation of cyclin D1 and the initiation of DNA replication by transcriptional regulation of 





ZONAB affects cell cycle progression by two distinct mechanisms. Firstly, it regulates the 
nuclear accumulation of the cell division kinase CDK4 via a direct interaction. Second, it 
regulates expression of genes encoding cell cycle regulators such as PCNA and cyclin D1 (Balda 
et al., 2003; Sourisseau et al., 2006). These data lead us to suggest that during binding of HSPA4 
with HSP70 chaperone and their function to correct the misfolding proteins and folding of new 
synthesized proteins. ZO-1 binds to and keeps ZONAB inactive in the cytosol. Thus, inhibition of 
nuclear accumulation of ZONAB by its binding with ZO-1 reduces the nuclear pool of CDK4. A 
consequence of that is the inhibition of G1/S phase progression. When the process of folding and 
correction of misfolded proteins is successfully completed, HSPA4 translocates to plasma 
membrane and binds to ZO-1. Then, ZONAB interacts with CDK4 and this complex ZONAB - 
CDK4 codistributed to the nucleus, where they promoted G1/S phase transition. We expected that 
percentage of cells in S phase would be decreased in Hspa4-mutant testis as a result of cytosol 
accumulation of ZONAB and missfolded proteins. The arrest of cell cycle at G1 phase might be 
triggered the spermatocytes to initiate apoptosis. 
 
4.4 The cause of growth retardation in Hspa4-deficient mice 
  In several mouse models, growth retardation in early postnatal development has been 
shown to be a result of defect in growth hormone signaling. Growth hormone (GH), acting 
through its receptor (GHR), is essential for somatic growth, development and maintaining 
metabolic homeostasis. Growth hormone receptor-deficient (GHR–/–) mice exhibit proportional 
growth retardation and drastically diminished insulin-like growth factor- (IGF-1)  levels 
(Robertson et al., 2006). Insulin-like growth factor-I (Igf-1)-deficient animals have severe growth 
deficiency, organ hypoplasia and diminished survival (Baker et al., 1993; Liu et al., 1993; Powell-
Braxton et al., 1993; Liu et al., 1998; Wang et al., 1999). In addition, hepatocyte nuclear factor 1α 
(HNF-1α) is required for postnatal growth and development in mice. Growth retardation in Hnf-1 
α null mice was found to be due to downregulation of growth hormone -responsive genes that are 
crucial for growth and development (Lee et al., 1998). Therefore, HNF-1α -related growth 
retardation results from a defect in the GH signaling (Lin et al., 2008). To determine whether the 
growth retardation of Hspa4 -/- mice is due to defect in GH-signaling, we analyzed  the expression 
of two GH- responsive genes, Amyloid P component (APCS) and solute carrier organic anion 
transporter family, member 1b2 ( SLCO1B2) , in liver of wild-type and Hspa4-/- animals. The 
results suggested that GH-signaling is not altered in Hspa4-/- mice. 
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Other mouse models reveal that growth retardation is due to malabsorbtion of lipids in the 
intestine. Fat malabsorption is one of several causes, which are contributing to growth retardation 
in glial cell line–derived neurotrophic factor family receptor α2 (Gfrα2)-null mice (Rossi et al., 
2003).  During fat absorption in the intestine, luminal digestion products of dietary fats are 
absorbed across the microvillus border of the enterocyte. Apolipoprotein B (apoB) and apo AIV 
are known to have a particularly critical role in the assembly of the triglyceride-rich lipoproteins. 
(Young, 1990; Havel and Kane, 1995; Kane and Havel, 1995). ApoA-IV may physically interact 
with ApoB in the secretory pathway to modulate the process of triglyceride-rich lipoprotein 
assembly and secretion (Gallagher et al., 2004). The chylomicron-deficient mice lack all apoB 
expression in the intestine, which prevents the assembly and secretion of TG-rich lipoproteins 
from the intestine. These mice accumulate massive amounts of cytosolic fat droplets within the 
absorptive enterocytes of the intestine and manifest severe intestinal fat malabsorption and -
retarded growth (Young et al., 1995). To address the question whether growth retardation in 
Hspa4-deficient mice is due to lipid malabsorption, we determined the expression levels of ApoB 
and ApoAIV in liver and intestine of Hspa4-/- and wild-type. This expression analysis indicated 
that ApoB mRNA level is upregulated in intestine and liver of  Hspa4-/- mice , while ApoAIV is 
higher in  intestine of Hspa4-/- mice compared with wild-type animals. However, Held (2008) 
found in Western-blot analysis that the ApoB levels markedly reduced in Hspa4-/- intestine. It has 
been reported that yeast HSP110, SSE1p, associates with and stabilizes ApoB (Hrizo et al., 
2007). These results suggest that HSPA4 might stabilize ApoB and overexpression of ApoB gene 
in Hspa4-/- mice is due to feedback regulation of ApoB gene in a consequence of ApoB 
degradation. 
 
4.5 Role of Hspa4 in skeletal muscle development 
Mammalian skeletal muscle consists of multinucleated myofibers which are formed 
during development by fusion of mononucleated muscle progenitors, some of which remain 
associated to adult myofibers as satellite cells, which is a specific type of stem cells (Ciciliot and 
Schiaffino, 2010). Adult skeletal muscle fibers are terminally differentiated. Muscle growth and 
regeneration are accomplished by proliferation of satellite cells. In the unperturbed state, satellite 
cells remain in a nonproliferative, quiescent state. However, in response to stimuli such as 
myotrauma, satellite cells present around the damaged muscle become activated, proliferate, and 
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resulting myoblasts express myogenic markers (Fig. 4.2). Ultimately, these myoblasts fuse to 
existing muscle fibers or fuse together to form new myofibers during regeneration of damaged 
skeletal muscle (Bischoff et al., 1994; Schultz, 1996).   
Several knockout mouse models display growth retardation, which is a result of skeletal 
muscle myopathy. Analysis of these mouse models revealed that the skeletal muscle myopathy is 
either due to severe muscle degradation, impaired muscle regeneration or both. Severe muscle 
degradation was the main cause for the postnatal growth retardation of knockout mice for Bag3, 
serum response factor (SRF) and mammalian target of rapamycin (mTOR), respectively. Similar 
to skeletal muscle myopathy observed in Hspa4-deficient mice, Bag3-/- mice cease to gain weight 
after postnatal day 12 and die. Skeletal muscle of Bag3-/- animals showed a marked variation in 
myofiber size, with evidence of atrophic fibers characterized by non inflammatory myofibrillar 
degradation with apoptotic features (Homma et al., 2006). Few centrally located nuclei were 
found in Bag3-/- myofibers, suggesting absence of a regenerative response. In contrast, myofibers 
with centrally located nuclei can be detected in Hspa4-/- mice suggesting a regenerative response 
in Hspa4-/- mice following muscle degradation. However, we have not determined in this work 
whether the growth retardation of the Hspa4-/- is due to severe muscle degradation or impairment 
in the process of muscle regeneration. The mTOR knockout mouse displays severe skeletal 
muscle myopathy, displaying features of muscle dystrophy and metabolic myopathy leading to 
decreased growth rate, which starts at 4 weeks of age. By the age 13 week, mutant mTOR mice 
start to develop spinal deformity (kyphosis), a sign of muscle weakness, and most mutants 
eventually die between 22 and 28 weeks of age (Risson et al., 2009) .  
Impaired regeneration capacity is the cause for growth retardation in a number of gene 
knockout mouse models such for melanoma antigen, family D, 1 (Maged1), tetradecanoyl 
phorbol acetate-induced sequence 7 gene (Tis7) and for forkhead/winged helix transcription 
factor (Foxk1/Mnf). Maged1 deficiency results in defective cell cycle exit and impaired myotube 
maturation (Nguyen et al., 2010). While disruption of the Tis7 gene delayed muscle regeneration 
(Vadivelu et al., 2004). Foxk1−/− mice display growth retardation and a severe impairment in 
skeletal muscle regeneration following injury. Such impairment in muscle regeneration in 
Foxk1−/− skeletal muscle is due to a reduction in number of satellite cells and arrest cell cycle 
progression at G0/G1 phase (Hawke  et al., 2003). It is possible according to the hypothesis (Fig 
4.1) that the competition between the HSPA4 and ZONAB to bind with ZO-1 may be regulated 
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the transition of cell cycle at G1/S phase of proliferated satellite cells and the HSPA4 depletion 
results in a G1/S arrest in significant number of proliferated satellite cells. Other  possibility that 
the Hspa4-deficiency delays the withdrawal of myoblasts from the cell cycle to differentiation. 
ZO-1 is a tight junction adaptor protein that regulates gene expression and junction assembly. 
Aijaz et al. (2007) have reported that the interaction of HSP4A with ZO-1 is also important for 
junction formation and epithelial morphogenesis.  Thus, depletion of HSPA4 in Madin-Darby 
canine kidney epithelial cells (MDCK) retards junction assembly and inhibits epithelial 
morphogenesis. On the basis on these data, we propose that Hspa4 deficiency may impair the 
fusion of myogenic cells during skeletal muscle regeneration and formation of new myofibers. 
 
4.6 Development of cardiac hypertrophy in Hspa4-deficient mice. 
Cardiomyocytes are terminally differentiated cells and lose their ability to proliferate soon after 
birth. Thereafter, cardiomyocytes grow in cell size without cell division to adapt to a demand for 
an increased workload. In a number of pathological conditions (eg, hypertension, valvular 
disease, myocardial infarction, and cardiomyopathy) that impose overwork on the heart, postnatal 
cardiomyocytes undergo cardiac hypertrophy. Although cardiac hypertrophy is initially 
compensatory for an increased workload, prolongation of this process leads to congestive heart 
failure, arrhythmia, and sudden death (Levy et al., 1990; Lorell and Carabello, 2000). Cardiac 
myocyte hypertrophy is associated with changes in gene expression including increased 
expression of immediate early genes (e.g. c-jun, c-fos and egr1), heat shock protein genes (such 
as Hsp70 and CryAB) and re-expression of  fetal genes  for atrial natriuretic factor (Anf), brain 
natriuretic peptide (Bnf ), β-myosin heavy chain 7 (Myh7) and  skeletal α actin 1 (Acta1)  . High 
expression of these fetal genes in heart has been used as indices of hypertrophy (Hoshijima and 
Chien, 2002; Dorn et al., 2003; Kumarapeli et al., 2008). Our RNA analysis revealed that 
expression levels of hypertrophic markers Anf, Myh7 and Acta1 are increased in Hspa4-null heart 
at postnatal day 15 compared with control littermates. Thereafter, a significant increase in 
expression levels of hypertrophic markers was observed through the postnatal developmental 
stage of Hspa4-deficient hearts. These results revealed that cardiac hypertrophy develops in the 






















Fig. 4.2 Satellite cell response to myotrauma. Skeletal muscle trauma or injury may be minor -
(e.g., resistance training) or may be more extensive (e.g., toxin injection, Duchenne muscular 
dystrophy). In response to an injury, satellite cells become activated and proliferate. Some of the 
satellite cells will reestablish a quiescent satellite cell pool through a process of self-renewal. 
Satellite cells will migrate to the damaged region and, depending on the severity of the injury, 
fuse to the existing myofiber or align and fuse to produce a new myofiber. In the regenerated 
myofiber, the newly fused satellite cell nuclei will initially be centralized but will later migrate to 






There are different stress pathways that modulate cardiac hypertrophy, such as 
P13k/GSK-3, dependent MAPK/ERK, IL6/gp130/STAT3 and calcineurin/NFAT signaling 
pathway (Ruwhof and van der Laarse, 2000; Frey and Olsen, 2003; Baines and Molkentin , 2005; 
Hill and Olson., 2008). To determine the molecular pathway which is responsible for the 
development of cardiac hypertrophy in Hspa4-null mice, we determined the activities of signaling 
pathways in heart of Hspa4-deficient mice.  
 
4.6.1 MAPK/ERK signaling pathway 
Mitogen-activated protein kinase (MAPK) signaling pathways consist of a sequence of 
successively acting kinases that ultimately result in the dual phosphorylation and activation of 
terminal kinases such as p38, c-Jun N-terminal kinases (JNKs), and extracellular signal-regulated 
kinases (ERKs) (Widmann et al. 1999). MAPK pathways provide an important link between 
external stimuli and the nucleus via phosphorylation and regulation of multiple transcription 
factors. The MAPK signaling cascade is initiated in cardiac myocytes by G protein–coupled 
receptors (angiotensin II, endothelin-1, and adrenergic receptors) and cardiotrophin-1 (gp130 
receptor), and by stress stimuli (Sugden and Clerk 1998).  Once activated, p38, JNKs and ERKs 
each phosphorylate of a wide array of intracellular targets that includes numerous transcription 
factors resulting in the reprogramming of cardiac gene expression as part of the hypertrophic 
program (Bueno and  Molkentin., 2002) (Fig. 4.3). The ERK family members, ERK1 (p42) and 
ERK2 (p44), are directly phosphorylated by two MAPK kinases, MEK1 and MEK2 (Garrington 
and Johnson 1999). Transgenic overexpression of MEK1, that activates ERK1/2, results in 
considerable cardiac hypertrophy (Bueno et al., 2000). Glennon et al., (1996) demonstrated that 
antisense oligodeoxynucleotides against the ERK isoforms p42 and p44 inhibited the 
morphological changes of hypertrophy in cardiomyocytes exposed to phenylephrine. MAPK/ERK 
signaling was found to mediate cardiac hypertrophy in several mouse models (Table 4.1). 
Deletion of Smad4, which is the central intracellular mediator of TGFβ signaling, resulted in 
cardiac hypertrophy and fibrosis. Phosphorylated extracellular signal-regulated kinase (ERK) 1/2 
and mitogen-activated protein kinase-ERK (MEK) 1 were increased in the Smad4 mutants (Wang 
et al., 2005). To investigate whether the activation of MAPK signaling is responsible for 
development of cardiac hypertrophy in Hspa4-null mice, we analyzed the expression of ERK 1/2 




Table 4.1. Activated signal pathway in different mouse models for cardiac hypertrophy 
Knockout mice Activated signaling pathways  
Natriuretic peptides receptor1 
 (Npr1-/-) 
 calcineurin–NFAT ( Ellmers et al., 2007) 
α B-crystallin (CryAB) /Hspb2 
CryAB-/-/Hspb2-/- 
calcineurin-NFAT pathway (Kumarapeli et al., 
2008) 
cardiac myosin binding protein 
C (cMyBP-C-/-) 
 MAPK pathway including JNK, p38-MAPK but 
not ERK pathway ( Eijssen et al., 2008) 
 Heat shock protein 70 ( Hsp70-/-) 
 
JNK, p38-MAPK, and Raf-1/ERK. (Kim et al., 
2006) 
 
Forkhead box transcription 
factor,O3(Foxo3-/-) 
Calcinurin/NFAT signaling ( Ni et al., 2006) 
Neurofibromatosis type 1 (Nf1-/-
) 
Ras-Erk pathway (Xu et al., 2009) 
Mitogen-activated protein kinase 
kinase (Mkk4-/-) 
JAK-calcineurin-NFAT signaling pathway (Liu et 
al., 2009) 
 
Ras associated with diabetes  
GTPase (rad-/-) 
CaMKII pathway (Chang et al., 2007) 
Profilin 1 (Pfn1 -TG) JNK and ERK pathways (Moustafa-Bayoumi et 
al., 2007) 
Adiponectin (Adipoq-/-) ERK signaling pathway (Shibata et al., 2004) 
The Insulin-like Growth Factor 
1 Receptor (IGF1R-TG) 
PI3K pathway and the mitogen-activated protein 
kinase (MAPK) pathway (McMullen et al., 2004) 
mothers against decapentaplegic 
homolog 4 (Smad4-/-) 
MEK1–ERK1/2 signaling (Wang et al., 2005) 
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angiotensin converting enzyme 2 
(Ace2-/-) 
AT1-ERK1/2, JNK1/2 and p38 pathways (Oudit 
et al., 2007) 
 
4.6.2 IL-6-gp130-STAT3 signalling pathway 
Activation of the JANK/STAT pathway by overload was found to be mediated by 
glycoprotein 130 receptor (gp130), and at least cadiotrophin-1(CT-1) and IL-6 were involved in 
activation of this pathway (Pan et al., 1997). Binding of ligands (i.e. member of interleukin (IL)-6 
family such as IL-6 and CT-1) to gp130 receptor, leads to formation of dimers of gp130 and 
activated JAKs (Kishimoto et al., 1994). As presented in figure 4.4, STAT factors bind to certain 
phosphotyrosines of gp130, leading to phosphorylation by JAK. Phosphorylated STAT factors 
form homo- and hetero- dimers, and translocate to the nucleus, where they induce gene 
expression (Kamimura et al., 2003). It has been found that induction of gp130-dependent 
signaling leads to activation of both MAPK and JAK/STAT pathways (Hoshijima and Chien., 
2002). Specifically, STAT3 is translocated to the nucleus in response to gp130 activation, which 
results in the induction of genes involved in hypertrophy and survival pathways (Yamauchi-
Takihara   and Kishimoto, 2000). Overexpression of STAT3 in transgenic mice is sufficient to 
induce cardiomyocyte hypertrophy in vitro (Kunisada et al., 1998) and in vivo (Kunisada et al., 
2000). Eijssen et al. (2008) reported that  the lack of the cMyBP-C protein resulted in cardiac 
hypertrophy, which is mediated by activation of the gp130/STAT3 and MAPK signaling 
pathways. We examined whether STAT3 activation is involved in cardiac hypertrophy in Hspa4-
mutant mice. Protein analysis revealed that the levels of phosphorylated STAT3 in Hspa4-/- hearts 
are not significantly different from that in wild-type. This data suggest that gp130/STAT3 
pathway is not involved in development of cardiac hypertrophy of Hspa4-/- mice.  
 
4.6.3 Calcineurin/NFAT signaling pathway 
Neuroendocrine factors such as angiotensin II (Ang II) and endothelin-1 (ET-1) can 
stimulate G protein-coupled receptors (GPCRs). GPRCRs are typically coupled to G proteins, 
which lead to elevation of interacellular Ca2+. An increase in cytoplasmic Ca2+ binds to 
calmodulin and activates calcineurin, which can dephosphorylate NFATs (nuclear factors of 
activated T-cells) (Fig. 4.5). Dephosphorylated NFATs migrate into the nucleus and promotes 
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Fig. 4.3 Schematic representation of the activation of MAPK pathway. Activation of specific 
MAPKs involves highly regulated and modulated cascades of phosphorylation events mediated 
by sequential and concerted activation of upstream kinases. ERKs are phosphorylated by 





















Fig. 4.4. Binding of ligands to their cytokine receptors, such as cardiotrophin-1 (CT-1) leads to 
phosphorylation and activation of receptor-JAK complex with subsequent recruitment of STATs. 
Activated STATs by  migrate into the nucleus, and bind to promoters of targeted genes and 
stimulate gene transcription (Ruwhof  and van der Laarse, 2000).  
 
 
Genetic manipulation of signaling pathways in mice and biochemical analyses have shown that 
calcium/calmodulin (Ca2+/Calm)-dependent signaling plays a pivotal role in pathological cardiac 
hypertrophy (Wilkins et al., 2004). NFAT and GATA4 cooperatively activate transcription of 
hypertrophic gene program, including Anf and Bnf genes. Anf and Bnf may create negative-
feedback loop that suppress calcineurin activity (Tokudome et. al, 2005). Deletion of several 
genes such as  Npr1, CryAB/HspB2, Foxo3 and Mkk in mice leads to activate calcineurin/NFAT 
signaling and induces hypertrophic responses (summarized in table 4.1) (Ni et al., 2006; Ellmers 
et al., 2007; Kumarapeli et al., 2008; Liu et al., 2009). In our current study we have determined 
whether the inactivation of the Hspa4 gene stimulates the activity of calcineurin-NFAT signaling 
pathway. Expression analysis revealed that calcineurin/NFAT pathway is significantly activated 





Fig 4.5 Calcineurin/NFAT signaling pathway. Activation of G protein-coupled or mechanical 
stretch receptors leads to an elevation of intracellular Ca2+ and activation of the calmodulin-
regulated phosphatase, calcineurin. Calcineurin activation causes nuclear localization of NFAT 
transcription factors by direct dephosphorylation. Calcineurin also directly activates nuclear 
MEF2 factors .These factors, along with GATA-4 and other partners cooperatively activate 
transcription of the hypertrophic gene programme ( Wilkins  and  Molkentin, 2002). 
 
Endothelin 1 (ET-1), a potent vasoconstrictor peptide expressed by endothelium, is also 
upregulated in the heart in response to a variety of stresses (Shohet et al., 2004). ET-1 activates 
two G-protein-coupled receptors, endothelin A (ETA) and endothelin
 B (ETB), with 
approximately equal affinity (Arai et at., 1990, Sakurai et at., 1990).  The binding of ET-1 to both 
ETA and ETB receptors in cardiomyocytes results in activation of G protein signaling and 
increased intracellular calcium (Beyer, et at., 1995). ET-1 and its receptors mediate stress-
induced remodeling in the mammalian heart. In vitro experiments show that ET-1-mediated 
activation of either ETA or ETB receptors on cardiomyocytes results in cellular hypertrophy
 (Ito et 
at., 1993a; Cullen et at., 2001). ET-1 acts as a local factor involved in cardiac and craniofacial 
development, as well as in the regulation of cardiac contractility and hypertrophy (Kedzierski and 
Yanagisawa 2001). It has been reported that ET-1 stimulates the accumulation of Hsp 27 
(Kawamura et al. 1999) and Hsp70 (Pan et al., 2004). In our present study, ET-1, ETA and ETB 
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expression levels were markedly increased in heart of Hspa4-null mice at 3 months. We suggest 
that HSPA4  protect cells against deleterious stimuli after induction of ET-1 in response to stress. 
Calmodulin1 (CALM) is a small cytoplasmic Ca2+ binding protein that regulates 
numerous cellular activities. CALM may exert its action through a direct interaction with its 
target proteins or indirectly by regulating the activity of Ca2+/CALM-dependent protein kinase 
and CALM stimulated protein phosphatase (calcineurin) (Maier and Bers, 2002; Saimi and Kung, 
2002). Calm transgenic (Calm-TG) mice develop marked cardiac hypertrophy and exhibit up-
regulation of calcineurin, atrial natriuretic factor (ANF) and β-myosin heavy chain gene 
expression in the heart during the first 2 weeks after birth (Obata et al., 2005). In the present 
study calmodulin 1 expression level was found to be upregulated in heart of 3-month-old Hspa4-/- 
mice. We suggest that calmodulin, which is a central mediator of several hypertrophic-signalling 
pathways, mediates the cardiac hypertrophy that occurs in response to the lack of Hspa4.  
The activity of calcineurin is influenced by cofactors known as modulatory calcineurin-
interacting proteins (MCIPs) or calcipressins (Rothermel et al., 2003). MCIP1 is upregulated by 
calcineurin signaling and has been proposed to function in a negative feedback loop to modulate 
calcineurin activity (Vega et al., 2003). The MCIP1.4 isoform has been shown to be tightly 
controlled by an alternative promoter containing 15 cis-acting elements of transcription factor 
NFAT cis-acting elements in the intron located upstream of MCIP1 exon 4 (Yang et al., 2000). 
MCIP1.4 expression can serve as a functional surrogate for calcineurin activity (van Rooij et al., 
2004). Because MCIP1.4 is a target gene for activated NFAT transcription, MCIP1.4 expression 
is a better marker for calcineurin activity than calcineurin protein level (Ni et al., 2006). 
Calsarcin-1 overexpression in transgenic mice prevents AngII-induced cardiomyocyte 
hypertrophy via inhibition of calcineurin signaling, which results in downregulation level of 
MCIP1.4 (Frank et al., 2007). In addition, mice lacking calsarcin-1 are sensitized to calcineurin 
signaling and show accelerated cardiomyopathy in response to pathological biomechanical stress 
(Frey  et al., 2004). Foxo proteins decrease calcineurin phosphatase activity and repress both 
basal and hypertrophic agonist-induced expression of MCIP1.4. Furthermore, hearts from Foxo3-
null mice exhibit increased MCIP1.4 abundance and a hypertrophic phenotype (Ni et al., 2006). 
We have found that expression levels of  MCIP1.4  is increased 15-fold in heart of 3-month-old 
Hspa4-/- mice compared to wild type mice. These results indicate that activation of calcineurin-




Activated NFAT transcription factor induces in collaboration with transcription factor Mef 
and GATA4 the expression of hypertrophic genes such Anf, Bnf and Myh7 (Akazawa and  
Komuro, 2003). In current study, RNA analysis revealed the significant increase in expression of 
Mef2 and GATA4 in the   heart of Hspa4-/- mice 
Histone deacetylases (HDACs) regulate chromatin remolding. Phosphorylation of class II 
HDACs are regulated by various signal-transduction pathways. For example prohypertrophic 
signals modify HDAC kinases such as protein kinase D (PKD), PKC and Calm Kinase, which 
phosphorylate HDACs, resulting in their subsequent nuclear export.  Histone deacetylases 
(HDACs) have been shown to associate with and repress MEF2 activation (Miska et al., 1999;  
Lu et al., 2000a, b; Youn et al., 2000). In hypertrophic heart of Calm kinase IV transgenic mice, 
MEF2 activation was suggested to occur through phosphorylation and dissociation of class II 
HDACs from MEF2 (Passier et al., 2000; Zhang et al., 2007). Ellmers et al. (2007) showed that 
Hdac 7a expression was increased in hypertrophic heart of Npr1–/– males. Here the Expression 
level of Hdac 7a was increased in RNA of Hspa4-null hearts at 18 days and 3 months.  This 
finding let us suggest that calmodulin and its kinase contribute to cardiac hypertrophy in Hspa4-
null hearts through nuclear export of HDAC7 by phosphorylation and MEF2 transcription factors 
activation. Finally figure 4.6 gives our proposal for a pathway that modulates the cardiac 
hypertrophy of Hspa4-/- mice.  
 
4.6.4 Cardiac fibrosis in Hspa4-/- mice 
Cardiac fibrosis is a classical feature of hypertrophy and is characterized by the expansion 
of the extracellular matrix due to the accumulation of collagen, particularly collagen types I and 
III (Manabe et al. 2002). TGF_β stimulates fibroblast growth, enhances collagen synthesis, and 
suppresses collagen degradation (Mehta and Attramadal, 2007). TGF_β is an important mediator 
of cardiac hypertrophy induced by Ang II (Williams, 2001; Schultz et al., 2002). It plays an 
important role in myofibroblast differentiation during wound healing and fibrocontractive 
diseases by regulating the expression of alpha-SM actin in these cells (Desmoulière et al., 1993). 
In our study, collagen 1, collagen II and TGF_β expression levels were markedly increased in 3-



















Fig. 4.6 Schematic representation of our proposal signaling pathways contributing to cardiac 
hypertrophy in Hspa4-null mice. Hypertrophic stimuli acting via the α subunit of ganine 
nucleotide-binding proteins after binding of G protein-coupled receptors (GPCRs), recruit PLCβ 
to the membrane, where it hydrolyses phosphatidylinositol 4,5 bisphosphate (PIP2), releasing 
inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). IP3 binds to receptors in the 
sarcoplasmic reticulum (SR), releasing calcium. The increase in cytosolic [Ca2+] together with 
calmodulin activates the protein phosphatase calcineurin. Calcineurin dephosphorylates several 
residues in the amino-terminal region of the transcription factor NFAT, allowing it to translocate 
to the nucleus and activate transcription of hypertrophic response genes. Calm regulates 
myogenesis and prevents formation of MEF2/HDAC complexes by inducing phosphorylation and 
nuclear export of HDACs. MCIP1.4 proteins actually facilitate Calcineurin activity for specific 





The late increase in the expression of collagen 1, collagen III and TGF-ß in 3-month-old Hspa4-/-  
mice indicates that in this mouse model of cardiac disease, hypertrophy occurs in early postnatal 
life, whilst the fibrotic response occurs later .  
 
4.6.5 Role of heat shock in heart protection 
Hypertrophic growth of cardiomyocytes is a result of different physiological and 
pathological stresses. Heat shock proteins were orginally discovered as proteins, whose 
expression is induced by heat shock. Subsequent experiments have revealed that HSPs expression 
is also induced by different cellular stresses, including mechanical ischemia/hypoxia and 
neural/hormonal. Therefore, this generic stress response molecule such HSP may also have a 
highly specific role in regulating cardiac hypertrophy under pathological stimulation (Vondriska 
and Wang, 2008).  A number of studies have shown that HSPs in the heart have a protective 
effect against severe stress such as mechanical stress or pressure overloaded (Morimoto, 1993). 
These results have been obtained by analysing the effects of overexpression of an individual HSP 
in cultured cardiac cells and in the heart of transgenic animals. Kumarapeli, et al. (2008) showed 
that Cryab/HspB2 deficiency activates the NFAT/calceneurin signaling and induces cardiac 
hypertrophic responses at the unstressed or minimal stress conditions and exacerbates cardiac 
malfunction on pressure overload. In contrast, Cryab overexpression significantly attenuates 
pressure-overloaded. Overexpression of NFAT-targeted gene MCIP1.4 was observed in 
Cryab/Hspb2- deficient heart. Kim et al. (2006) studied the role of Hsp70 in maintaining cardiac 
contractility and calcium handling by investigation of Hsp70-knockout mice. We have shown that 
the depletion of HSPA4 causes cardiac hypertrophy, which suggests that HSPA4 confers 
cardioprotection against stimulated or metabolic stress. To confirm the cardioprotective effect of 
HSPA4, we have to determine which stress induces the expression of HSPA4 in heart. Generation 
of Hspa4 transgenic mice, in which HSPA4 is specifically overexpressed in cardiomyocytes, will 
help us to determine the protective effect of Hspa4 against different stresses that induces cardiac 
hypertrophy. 
 
4.6.6 Expression profiles of Hspa4-/- heart 
With the emergence of the DNA microarray technique, it is possible to have a more 
comprehensive characterization of the hypertrophic response at the global gene expression than in 
traditional single-gene studies (Liew and Dzau 2004, Liew 2005). Microarray analysis was 
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performed to identify gene expression profiles and expand the knowledge of pathways regulating 
the development of cardiac hypertrophy in Hspa4-null mice. Results of DNA microarray analysis 
identified 98 differentially expressed genes that were upregulated or downregulated in Hspa4-null 
heart at least 1.5 fold with P values of < 0.05. Differentially expressed genes related to oxidative 
stress, ion channel signaling and synaptic junction were selected for further study (Table 3.2). 
Result of DNA microarray showed a wide spectrum of changes in gene expression, which may be 
responsible for development of cardiac fibrosis and hypertrophy of Hspa4-null mice. A key 
finding of the microarray analysis was that expression of hypertrophic genes Anf, Bnf, Acta1 and 
Myh7 was upregulated. These results confirm our hypothesis suggesting that pathologic 
hypertrophy of Hspa4-/- heart is accompanied by reactivation of fetal gene programs. DNA 
microarray studies of other genetic animal models of hypertrophy revealed that activation of Anf 
and/or Bnf seems to be the most predominant change at the gene expression level (Aronow et al. 
2001; Fischer, et al., 2005; Mirotsou et al. 2006).  
Monoamine oxidases (MAOs) are mitochondrial flavoenzymes, which catalyze oxidative 
deamination of catecholamines (CAs) and biogenic amine such as serotonin. During this process, 
they generate hydrogen peroxide (H2O2), which can potentially source of oxidative stress in the 
heart. MAOs exist in two forms, MAOA and MAOB (Shih et al., 1999). Both enzymes catalyze 
the oxidative deamination of monoamine neurotransmitters such as serotonin, norepinephrine and 
phenylethylamine (Youdim and Bakhle, 2006; Bortolato et al., 2008). Maoa-knockout mice have 
elevated brain levels of serotonin, norepinephrine and to a lesser extent, dopamine (Cases et al., 
1995), whereas only 2-phenylethylamine levels are increased in Maob-Knouckout mice (Youdim 
et al., 2006). Maoa-KO mice displayed exaggerated ventricular hypertrophy which is due to 
increase serotonin levels (Lairez et al., 2009). Cardiomyocyte receptor that couples to Gq 
stimulates cardiomyocyte hypertrophy, the most important receptor of which are the 1-adrenergic 
receptors for norepinephrine and phenylephrine (Molkentin and Dorn  2001). Mice that are 
unable to synthesize norepinephrine, because of targeted disruption of the dopamine ß-
hydroxylase gene, exhibit less cardiac hypertrophy and preserved ventricular function after 
surgical constriction of the transverse aorta (Esposito et al., 2002). In contrast, depletion of 
MAOA was associated with an increase in whole blood serotonin and exacerbates left ventricle 
thickening and fibrosis (Lairez et al., 2009). The present results showing reduced Maob 
expression in heart of 25-day and 3-month-old Hspa4-null mice suggest that the reduction of 
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Maob in Hspa4-mutant mice increases the catecholamine stress and blood pressure. Such increase 
of catecholamine stress and blood stress induces cardiac hypertrophy via receptor 1-adrenergic 
receptors that initiate G- protein signaling cascade.  
The main receptors involved in the regulation of heart muscle contraction are prototypical 
G protein-coupled receptors in response to neurohumoral induction (Rockman et al., 2002). They 
activate heterotrimeric G proteins that are comprised of α-, β-, and γ-subunits (Offermanns , 
2003). The activation of a G protein is accomplished by the dissociation of its α subunit from the 
γβ dimer, both of which in turn modulate target effectors (Zhu and Birnbaumer, 1996). Guanine 
nucleotide binding protein also known as alpha O (Gnao1/GαO) protein belongs to the G-alpha 
family. Targeted deletion of both isoforms of Gαo in mice lead to altered
 potassium and calcium 
channel regulation in neuronal cells and neurological abnormalities (Valenzuela et al., 1997; 
Tanaka et al., 1999; Greif et al., 2000; Kamp and Hell, 2000). Nishida  et al. (2000) demonstrated 
that hydrogen peroxide (H2O2) induced Gnao1 expression in rat neonatal cardiomyocytes. The α-
Adrenoceptors mediate the contractile response in rat aorta by coupling to both binding of Gq 
protein and the GNAO1 protein (Gurdal et al., 1997). A constitutively active form of GNAO* 
(Gαo*) exerts positive effect on cardiac Ca
2-cycling and contractile function in ventricular 
myocytes of Gnao* transgenic mice (Zhu et al., 2008). The present results show a significant 
increase of Gnao1 expression in heart of 25-day- and 3-month-old Hspa4-null mice. We suggest 
that increase of GNAO1 activates phospholipase C, resulting in production of inositol 
trisphosphate and release of intracellular calcium after binding of norepinephrine to α-
adrenoceptor (AR) in Hspa4-knockout. This results support the involvement of this pathway in 
the development of cardiac hypertrophy.  
Insulin-like growth factor-binding protein3 (Igfbp3) is one of six members of protein 
family that bind with insulin-like growth factor1 (IGF1).  These IGFBPs are capable to increase 
the half –life of IGF1 in the circulation and are able to either potentiate the cell specific effects of 
IGF1 or act as inhibitors to block its action by preventing delivery to responding cell types (Ito et 
al., 1993b). Murphy et al. (1995) reported that expression of human IGFBP3 in transgenic mice 
causes organomegaly (heart, liver and spleen). Henson et al. (2000) demonstrated that Igfbp3 
expression was significantly increased in heart of rodent models for heart hypertrophy. Increased 
IGFBP-3 protein was shown to induce transcription of atrial natriuretic factor (Anf) and β-myosin 






ANGII, cardiotrophin-1 and IGF-1. In this study, Igfbp-3 transcript was markedly increased in 
heart of Hspa4-/- mice at 25 days and 3-months of age. 
Prolongation of the repolarization time has often been observed before fibrosis or clinical 
signs of heart failure in animal model become evident. Cardiac hypertrophy is characterized by 
electrical remolding with increased risk of arrhythmogenicity. This electrical remodeling process 
is at least partially determined by a reprogramming of cardiac gene expression and the 
reactivation of ‘fetal’ cardiac genes. Among the differentially expressed genes in the Hspa4-null 
heart are genes encoding ion channel proteins. The hyperpolarization-activated cyclic nucleotide-
gated channel (HCN) gene family, Ca2+,  K+ and Na+ channels playing an important role in the 
electrical remodeling process (Boixel et al., 2006).  Four genes that encode HCN channels have 
been identified: Hcn1, Hcn2, Hcn3, and Hcn4. HCN channels carry an inward current, the 
depolarizing Na/K current If, that underlies cardiac pacemaker activity (Jongbloed et al., 2008). 
KCNE1 encodes the potassium ion channel β subunit that co-assembles with KCNQ1 to produce 
a channel that mediates the slowly activating delayed rectifier potassium current, IKs (Barhanin 
et al., 1996; Sanguinetti et al., 1996). Loss of Kcne1 function prolongs ventricular action 
potentials in humans and in Kcne1–/–  mice  and display unexpectedly shortened atrial action 
potentials and prolonged electrocardiographic QT intervals (Temple et al., 2005).  Leucine-rich 
glioma inactivated gene 1 (Lgi1) regulates voltage-gated potassium channels assembly of Kcna1, 
Kcna4 and Kcnab1 and positively regulates synaptic transmission mediated by AMPA-type 
glutamate receptors (Schulte et al., 2006; Diani et al., 2008; Sagane, 2008). The expression of the 
Hcn2, Hcn4, as well as Kcne1 and Kcne2 genes in cultured ventricular cell, which are isolated 
from acute myocardial infarction rat hearts, underwent dynamic expression changes, reaching 
peak levels at 1 or 2 weeks post-acute myocardial infarction. The increased expression may be 
related to ventricular arrhythmogenesis after acute myocardial infarction (Xia et al., 2010). In 
current study, we showed that expression of Kcne1 transcripts in heart of Hsp4a-null mutant is 
upregulated. In contrast, the expression levels of Kcnd2, Hcn1 and Lgi1 are significantly 
decreased in Hspa4-mutant heart compared with wild type. We propose that electrical remodeling 
is associated with ventricular hypertrophy in Hspa4-null.  
Summary 
5. Summary 
The aims of this study were to determine the underlying causes of male infertility, growth 
retardation and cardiac hypertrophy in Hspa4-/- mice. 
In order to identify the spermatogenic stage, at which spermatogenesis is affected by 
Hspas4 deficiency in mice with hybrid C57BL/6J x 129/Sv genetic background, we performed 
histological and immunological analysis. Analysis of germ cell development during juvenile life 
of Hspa4-/- mice showed an arrest of first wave of spermatogenesis in late stage of prophase I. 
RNA analysis  showed a marked reduction in expression of late meiotic and postmeiotic-specific 
marker genes, whereas expression of early meiotic-specific genes was unaffected in the Hspa4-/- 
testes.  These results suggest that HSPA4 is required for the regulation of diverse chaperone 
processes and cell cycle during germ cell progression.  
The second aim of this study was concentrated to study the cause of growth retardation in 
Hspa4-/- mice with inbred 129/Sv genetic background. To investigate whether growth retardation 
is due to skeletal muscle myopathy, histological analyses of different skeletal muscles were 
carried out. Histological analyses revealed that Tibialis anterior, Vastus intermedius,  Soleus and 
paraspinal muscles of Hspa4-/- adult mice displayed myopathic changes. Moreover, myopathic 
change was already present at an early postnatal stage of Hspa4 -/-   mice development. This 
suggested that skeletal muscle myopathy is the cause of growth retardation. Furthermore, these 
results suggest that HSPA4 has protective effect that confers the protection of skeletal muscle 
against mechanical or metabolic stress, which induce skeletal muscle degradation.  
To determine whether skeletal muscle myopathy is also realized in heart as hypertrophic 
cardiomyopathy, histological molecular analyses and two-dimensional directed M-mode 
echocardiograms were performed. Histological analyses revealed the development of cardiac 
hypertrophy and fibrosis in heart of Hspa4-deficient mice. Ultrastructure analysis revealed 
myofibrillar disarray and disassembly in cardiomyocytes and increased collagen accumulation 
(fibrosis) in heart of Hspa4-deficient mice. Echocardiographic measurements further confirm the 
cardiac hypertrophy phenotype in Hspa4-null mice. To identify when the development of cardiac 
hypertrophy and fibrosis starts in Hspa4-/- hearts, we studied expression of hypertrophic and 




analyses. These results indicate that the development of cardiac hypertrophy and fibrosis in 
Hspa4-null mice starts in early postnatal life and let us to suggest that the early postnatal lethality 
in Hspa4-/- mice in an inbred 129/SV genetic background can be contributed to the progression of 
skeletal muscle myopathy and hypertrophic cardiomyopathy. In contrast to skeletal muscle and 
heart phenotype in Hspa4-/- mice with inbred background, histological analysis and expression 
analysis of hypertrophic genes showed that cardiac hypertrophy is not developed in Hspa4-/- mice 
with hybrid 129/Sv x C57BL genetic background.  
In order to identify the signal pathways that mediate cardiac hypertrophy in Hspa4-/- mice, 
we determined the expression of some genes and proteins, which are involved in Gp130/STAT3, 
MAPK and calcineurin-NFAT signalings, in heart of wild-type and Hspa4-/- mice. Results of these 
analyses suggest that STAT3 and MAPK signaling pathways are not responsible for the 
development of cardiac hypertrophy in Hspa4-null mice. On the contrary, increased activity of 
calcineurin/NFAT in Hspa4-/- heart seems to modulate the cardiac hypertrophy.  
Microarray analysis was used as a screening tool to identify altered gene expression in 
Hspa4-deficient heart at 25 days compared with that of wild-type mice. 98 genes were identified 
as differentially expressed. Several genes were selected and classified according to their function 
in the development of cardiac hypertrophy. To confirm the results of microarray analysis, 
quantitative real-time PCR was performed. We confirmed that genes involved in ion channel 
signaling (Kcne1, Kcnd2, Scn4a, Hcn1 and Irx4), in protection of cells against oxidative stress 
(Gnao1, Ptp4a1 and Mme1) and those inducing oxidative stress (Maob), are differentially 
expressed in heart of Hspa4  mice. The altered expression of these genes may be involved in the 
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